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Purpose: Cardio-respiratory physiotherapy for patients undergoing abdominal surgery has been found 
to be beneficial in improving lung function post-operatively and in the prevention and treatment of 
post-operative pulmonary complications (PPCs). The Blow Bottle, a Positive Expiratory Pressure 
(PEP) therapy device, is commonly used as an adjunct to physiotherapy. The Blow Bottle is low cost 
and can be easily made by the physiotherapist using readily available materials in the hospital setting. 
However, evidence to support the use of Blow Bottles in the post-operative management of 
abdominal surgery is minimal, with few studies reporting significant positive effects especially when 
compared to conventional cardio-respiratory physiotherapy techniques.  
Methodology: A randomized control was implemented in a public tertiary institution within the 
Western Cape. Patients admitted for open abdominal surgery via midline incision were eligible for the 
trial. Participants were randomly allocated to either the control group (CG) receiving conventional 
post-operative cardio-respiratory physiotherapy, or the intervention group (IG) who received the 
additional use of the Blow Bottle. Lung function and the development of post-operative pulmonary 
complications were the primary outcomes of this study. Lung Function was evaluated by means of 
spirometry testing and interpretation of Forced Expiratory Volume in 1 second (FEV1) and Forced 
Vital Capacity (FVC). The development of post-operative pulmonary complications were diagnosed 
using the criteria by Mackay et al. (2005) where changes from pre-operative findings of auscultation; 
temperature, X-ray and sputum are evaluated post-operatively and recorded using the Adapted 
Abdominal Physiotherapy Outcomes Data Sheet (A-APODS).  
Results: A total of 19 participants were enrolled in the study, n=11 (CG) and n=8 (IG), predominantly 
female (n=14) and admitted for cancer related abdominal surgery (n=9). There was a statistically 
significant (p<0.05) marked reduction in post-operative lung function from baseline across groups, 
62% in FEV1 and 47% in FVC on the first post-operative day. The FEV1 and FVC were similar across 
both the control and intervention groups for the first three post-operative days. On auscultation 
majority of participants had decreased breath sounds on the first post-operative day. However, no one 
participant developed a PPC across the duration of the study as diagnosed using the criteria by 
Mackay et al. (2005).  
Conclusion: Whether the additional use of the Blow Bottle is more beneficial than conventional post-
operative cardio-physiotherapy alone is inconclusive due to the incremental drop out of participants 
from the study and small sample size. In this study there was however a significant reduction in lung 
function post-operatively. This mandates the need for further research investigating the abdominal 
surgical field and the use of devices to improve lung function, such as the Blow Bottle, as literature is 
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
1.1 Background 
Open abdominal surgery is associated with reductions in lung function and diminished ability by the 
patient to breathe deeply and cough effectively. Both the surgery and the subsequent impairments 
increase the risk for the development of post-operative pulmonary complications (PPCs) such as 
pneumonia and atelectasis (Brooks-Brunn, 1995; Silva, Li & Rickard, 2012). The development of 
PPCs is associated with a prolonged hospital stay and subsequent increased costs (Tzani, Chetta & 
Olivieri, 2011). Cardiorespiratory physiotherapy regimes, involve the application of techniques aimed 
at increasing patients’ post-operative respiratory and general function. In the abdominal surgical 
population, cardiorespiratory regimes including early mobilization and deep breathing exercises have 
been found to be beneficial in improving post-operative lung volumes and decreasing the risk for the 
development of PPCs (Manzano, Carvalho, Fernandes, Saraiva-Romanholo & Vieira, 2008; Mackay, 
Ellis & Johnston, 2005; Richardson & Sabanathan, 1997). 
Positive Expiratory Pressure (PEP) therapy is a technique that physiotherapists can employ to assist 
airway clearance and improve lung function (Clini, 2009). The Blow Bottle is an example of a PEP 
therapy device commonly used by physiotherapists within the hospital setting (Johnston, James & 
Mackney, 2013; Johansson, Sjöholm, Stafberg & Westerdahl, 2013). However, the evidence for its 
effectiveness in the treatment of patients, following abdominal surgery, has been minimal and 
outdated (Johnston, James & Mackney, 2013; Johansson et al., 2013; Fiore, Chiavegato, Paisani, 
Colucci, 2010; Orman & Westerdahl, 2010). This research therefore serves to investigate PEP therapy 
in the abdominal surgical population with specific reference to the use of the Blow Bottle as an 
adjunct to cardio-respiratory physiotherapy. 
 
Abdominal Surgery and Pulmonary Function 
Breathing is an essential task necessary to sustain life. The mechanism of breathing is achieved by the 
action of the respiratory muscles. The diaphragm plays a vital role in breathing as during inspiration 
the diaphragm muscle contracts, causing it to flatten and descend. This action thereby expands the 
thoracic cavity, allowing air to enter the lungs (Chuter, Weissman, Mathews, Starker, 1990; Roussos, 
1985). The expiratory muscles are not usually active during breathing. However, as ventilatory 
demands increase or forced expiratory manoeuvres are required, as during coughing and vomiting, 
expiratory muscles such as the abdominal muscles become active. The action of the abdominal 
muscles increases intra-abdominal pressure, which allows the diaphragm to move cephalad into the 
thoracic cavity and subsequently depresses the chest wall allowing air to be rapidly expelled from the 
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lungs (Roussos, 1985). Surgical procedures can affect the integrity of these muscles and thereby affect 
the process of breathing.  
 
The repercussions of abdominal surgery can be influenced by various factors such as the area of the 
surgery (upper versus lower abdominal surgery), the degree of difficulty (minor versus major 
abdominal surgery), the method of surgery (open abdominal surgery versus laparoscopic surgery) and 
the incision type (vertical versus transvers). These factors play a role as to the degree of post-
operative dysfunction the surgery may produce. The incidence of respiratory muscle dysfunction is 2-
5% with lower abdominal surgeries and 20-40% with upper abdominal surgeries. Although studies 
show that upper abdominal surgeries result in more post-operative pulmonary dysfunction, this result 
may not be limited to evidence regarding cholecystectomies, but may be similar for other surgeries 
such as liver resections (Siafakas, 2013). The difficulty of the surgery may also influence post-
operative function where minor surgeries such as tubal ligation result in less intra-operative handling 
than major surgeries such bowel resections (Joris, Kaba, Lamy, 1997). A major factor influencing 
post-operative pulmonary function is the surgical approach. Abdominal surgical procedures can be 
classified as either open (laparotomy via a vertical or horizontal incision) or closed (laparoscopic via 
the use of a scope). Abdominal surgery can be performed for procedures such as hernia repairs, gall 
bladder resection (cholecystectomy) and large bowel resection (hemicolectomy) (Manzano et al., 
2008). Various incision types (vertical, transverse and combined) can be employed in order to gain 
access to the abdomen during open abdominal surgery. The transverse incision has been found to be 
advantages as its effects on post-operative function is less detrimental than with vertical incisions. 
However, the vertical incision through the rectus abdominus muscle allows for rapid entry into the 
peritoneal cavity for exploratory purposes as incision site can be easily extended when required for 
more complex cases (Grantcharov & Rosenberg, 2001). An incision through the rectus abdominus 
muscle, as with open abdominal surgery, is invasive and disturbs both the abdominal muscles and 
diaphragm. To avoid a larger abdominal incision, where possible, a laparascopic approach is 
employed by means of smaller incisions. When compared to open abdominal surgery for 
cholestectomy, the laparoscopic approach resulted in less detriment to pulmonary function post-
operatively (Hasuki, Meši, Dizdarevi, Keser, Hadiselimovi, Bazardanovi, 2002). This finding is 
supported by several other authors (Osman, Serpil, Umit, Ebru, Bulent, Mete, Omer, 2009; Joris, 
Kaba & Lamy, 1997; Coelho, de Araujo, Marchesini, Coelho, de Araujo Coelho, 1993, Hasuki et al., 
2002; Joris, Kaba & Lamy, 1997). Therefore, laparascopic surgeries have since become a more 
popular approach.  
The disruption to the rectus abdominus muscle, adversely affects the patient’s ability to produce force 
expiratory manoeuvres as the rectus abdominus muscle forms a part of the muscles that assist in 
expiration (Roussos, 1985). Disruption to the diaphragm negatively affects the patient’s ability to 
13 
 
expand the chest and inspire (Siafakas, Mitrouska, Bouros, Georgopoulos, 1999; Frazee, Roberts, 
Okeson, Symmonds, Snyder, Hendricks, Smith, 1991; Chuter et al., 1990).  
Open abdominal surgery is associated with a large incision site, increased intra-abdominal handling 
during surgery, and may lead to increased post-operative pain (Joris, Kaba & Lamy, 1997). Pain, if 
not managed adequately post-operatively, can further affect the patient’s willingness to breathe 
deeply, cough effectively, and mobilize post-operatively (Tzani, Chetta & Olivieri, 2011; Richardson 
& Sabanathan, 1997). The type of  incision employed is therefore an  important factor  influencing 
post-operative lung function, as poor lung function may lead to the development of post-operative 
pulmonary complications (PPCs). 
 
Post-operative pulmonary complications (PPCs) 
The inability to cough and clear secretions adequately may lead to retention of secretions, which 
subsequently places the patient at higher risk of developing post-operative pulmonary complications 
(PPCs) (Kacmarek, Stoller & Heuer, 2013, Egans Fundamentals of Respitatory Care, p.904). 
O’Donohue (1992) characterized PPCs as “any pulmonary abnormality occurring in the post-
operative period that produces identifiable disease or dysfunction that is significant and adversely 
affects the clinical course” (O'Donohue, 1992). The term PPC is problematic as it includes a variety 
of complications such as pneumonia, respiratory failure, bronchospasm, atelectasis, and exacerbation 
of underlying chronic lung diseases (Smetana, 1999). As this umbrella-term encompasses a host of 
dysfunctions and not clearly defined in literature, PPCs are predominantly described in terms of the 
development of pneumonia and atelectasis (Pasquina, Tramèr, Granier & Walder, 2006; Grantcharov 
& Rosenberg, 2001; Brooks-Brunn, 1995). In addition to this poor definition, the criterion for the 
diagnosis of PPCs is not standardized leading to the varying criteria used in literature (Conde & 
Lawrence, 2008; Mackay, Ellis & Johnston, 2005; Smetana, 1999; Lawrence, Dhanda, Hilsenbeck, 
Page, 1996). Current literature tends to report different signs and symptoms that define the presence 
of PPCs, therefore making a true classification of a PPC, by means of specific criteria, difficult. The 

















Table 1: Summary of conflicting criteria for the diagnosis of PPCs 
Summary of conflicting criteria for the diagnosis of PPCs 
(Conde & 
Lawrence, 2008) 
(Browning, Denehy & Scholes, 2007) (Brooks-Brunn, 1995 and Hall, 
1996 as modified by Mackay, 
Ellis & Johnston, 2005 ) 
PPC was associated 
with a combination 
of the following: 
PPC was confirmed if 4 or more of the 
following signs and symptoms were present: 
PPC are confirmed if 3 or more 
of the following respiratory 
signs occurred within the same 




€ Shortness of 
breath 
€ Chest pain 
€ Temperature 
>38 ˚C 
€ Pulse rate > 
100 beats 
per minute 
▪ Chest radiograph report of 
collapse/consolidation 
▪ Raised temperature >38 ˚C on two or 
more consecutive days 
▪ SpO₂ <90% on room air on two 
consecutive days 
▪ Production of yellow or green sputum 
which is different to pre-operative 
assessment 
▪ An otherwise unexplained white cell 
count < 11X10⁹/L or prescription of 
an antibiotic specific for respiratory 
infection 
▪ Physician diagnosis of chest infection 
▪ Presence of infection on sputum 
culture report 
• Abnormal breath sounds on 
auscultation that differs from pre-
operative assessment 




breathing) that were 
additional to those 
found prior to surgery 
o Temperature >38 ˚C 
o Chest X-ray changes 
consistent with collapse, 
consolidation, or 
atelectasis 
o Increase in amount 
and/or changed colour 
of sputum produced, 
compared to what the 
patient reports is usual 
for them 
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PPCs are often reported in terms of atelectasis and pneumonia and are often reported together. This is 
as patients who exhibit clinical signs of increased temperature are often started on antibiotics (Hall, 
Tarala, Hall & Mander, 1991). Atelectasis can be classified as either resorption atelectasis or passive 
atelectasis. Resorption atelectasis occurs when retained secretions result in mucus plugging, causing 
areas of the lung to collapse. Passive atelectasis is caused by the patient’s inability to take deep 
breaths and persistently breathing at small tidal volumes and is further aggravated by poor mobility, 
as is commonly exhibited in patients following open abdominal surgery (Kacmarek, Stoller & Heuer, 
2013, Egans Fundamentals of Respiratory Care, p.904). Retained secretions may also increase the 
patient’s risk of developing post-operative pneumonia. Pneumonia that develops in hospitalized 
patients is commonly referred to as hospital-acquired pneumonia. Hospital-acquired pneumonia is 
defined as a lower respiratory tract infection that occurs in patients more than 48 hours after 
hospitalization and is caused typically by the spread of organisms such as Staphylococcus aureus and 
Enteric gram-negative bacilli between patients or equipment (Kacmarek, Stoller & Heuer, 2013, 
Egans Fundamentals of Respiratory Care, p.484-486).  
Open abdominal surgery, as discussed previously, is an invasive procedure that often results in 
reductions in pulmonary function, post-operative pain, negatively influences post-operative mobility, 
and thus places the patient at risk of developing PPCs (Hasuki et al., 2002; Richardson & Sabanathan, 
1997). Hall et al. (1991) suggested that PPCs occur in 19 to 76 percent of patients undergoing 
abdominal surgery (Hall et al., 1991). Fagevik Olsen et al. (1997) reported that PPCs occurred in 4.5-
8 percent of patients undergoing upper abdominal surgery (Schmidt, 1977; Stiller and Munday, 1992; 
Thorѐn, 1954, Olsén, Hahn, Nordgren, Lönroth, Lundholm, 1991). Other factors that further impact 
on lung volumes and the risk of the development of PPCs are the elderly, obese, smokers, and in 
patients with poor general pre-operative health (Smetana, 1999; Hall et al., 1991). PPCs have been 
found to be the main contributors to increased hospital stay and health costs (Tzani, Chetta & Olivieri, 
2011; Brooks-Brunn, 1995; Hall et al., 1991). Therefore, adequate post-operative pain relief, 
techniques to improve pulmonary function and early mobilization are essential in the prevention of 
PPCs. 
Cardio-respiratory physiotherapy post abdominal surgery 
Physiotherapy is suggested to play a valuable role in the prevention and treatment of PPCs post-
abdominal surgery (Richardson & Sabanathan, 1997). Post-operative lung expansion techniques used 
by physiotherapists are reported to lower the risk of atelectasis by increasing lung volumes (Smetana, 
1999). Manzano et al. (2008) reported improvements in oxygen saturation when comparing a chest 
physiotherapy regime to a control group of no intervention in the abdominal surgical population 
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(Manzano et al., 2008). Mackay, Ellis & Johnston (2005) investigated the use of physiotherapy in 
high-risk patients following open abdominal surgery. A total of 58 patients met the criteria, of which 
the results of 56 patients were included. This randomized control trial allocated patients into a group 
receiving early mobilization only and another group consisting of early mobilization, deep breathing 
exercises, and coughing. They found that there was no significance in outcomes between the two 
groups. The suggestion was that the addition of deep breathing exercises and coughing exercises to a 
programme, including early mobilization, did not significantly reduce post-operative pulmonary 
complications (Mackay, Ellis & Johnston, 2005).  
However, in an earlier comparative study investigating  breathing exercises such as the use of 
incentive spirometry (IS), intermittent positive pressure breathing (IPPB), and deep breathing 
exercises (DBE) results showed that DBE and IS respectively were more effective than no 
physiotherapy after abdominal surgery (Thomas & McIntosh, 1994). More than a decade later 
uncertainty still exists about the value of routine physiotherapy using these modalities (Pasquina, 
Tramèr, Granier, Walder, 2006). More recently, Hanekom et al. (2012) devised a treatment algorithm 
for the post-operative physiotherapy management of patients following upper abdominal surgery, 
which includes upright positioning, early mobilization, coughing with wound support, deep breathing 
exercises, and the use of Positive Expiratory Pressure (PEP) devices such as the Blow Bottle or PEP 
mask (Hanekom, Brooks, Denehy, Fagevik-Olsén, Hardcastle, Manie, Louw, 2012).  
 
Positive Expiratory Pressure (PEP) therapy 
Positive Expiratory Pressure (PEP) therapy involves the application of positive pressure during the 
expiratory phase in the spontaneously breathing patient. It is aimed at airway clearance and improving 
tidal volume and functional residual capacity and can be applied in the treatment of both surgical and 
non-surgical patients with respiratory complications (Clini, 2009; Johnston, James & Mackney, 2013; 
Orman & Westerdahl, 2010; Elkins, Jones & Van der Schans, 2006; Darbee, Ohtake, Grant, Cerny, 
2004; Tang, Taylor & Blackstock, 2010). The suggestion is that PEP therapy improves lung volume 
as the transpulmonary gradient increases by increasing the alveolar pressure. This assists in the 
prevention and treatment of atelectasis (Kacmarek, Stoller & Heuer, 2013, Egans Fundamentals of 
Respiratory Care, p.905). Furthermore, the positive pressure during expiration keeps the small 
airways open by improving collateral ventilation, and thereby assists in secretion clearance 
(Mestriner, Fernandes, Steffen, Donadio, 2009). Positive Expiratory pressure can be achieved, using 
no equipment, by means of pursed-lip breathing (Johansson et al., 2013). PEP therapy can be also be 
applied using devices manually constructed or devices that are commercially available. PEP devices 
can be classified as either flow or pressure generated devices where the PEP is either produced by 
passing the exhaled air through a fixed orifice whereby the pressure generated increases with the 
expiratory flow, or where the pressure remains constant regardless of the flow of exhaled air 
(Mestriner et al, 2009). 
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The “Blow Bottle” is one of the earliest forms of a manually constructed PEP device. It is the simplest 
form of a threshold-resistor PEP device (whereby the pressure remains constant regardless of flow). It 
consists of a bottle filled with water and a dwelling tube through which the patient is asked to blow 
(Ricksten, Bengtsson, Soderberg, Thorden, Kvist, Ricksten, 1986). It is also referred to in literature 
and in practice as the “Positive End-Expiratory Pressure (PEEP) Bottle”, “PEP Bottle” or “Bubble 
PEP” (Mestriner, Fernandes, Steffen & Donadio, 2009; Sehlin, Ohberg, Johansson, Winso, 2007). 
The Blow Bottle is typically used intermittently and is dependent on the patient’s ability to perform 
the expiratory manoeuvre (Orman & Westerdahl, 2010). It is commonly constructed using available 
hospital materials such as sterile water or saline solution bottles, together with suction tubing or 
urinary catheter tubing. The expiratory pressure produced by the manually constructed Blow Bottle is 
difficult to measure in practice, as it cannot be fitted with a manometer. However, investigations 
suggest that a water column of 10cm generates a pressure of 10cmH2O within the lungs, implying that 
the level of water is proportional to the positive pressure exerted within the lungs (Mestriner et al., 
2009; Sehlin et al., 2007). A laboratory study by Mestriner et al. (2009) described the optimum design 
parameters for a manually constructed Blow Bottle of which a water column of 10cm with a tube 
inner diameter of ≥ 8mm and an air orifice of ≥ 8mm. These parameters allow for the production of a 
threshold-resistor PEP device, where pressure is provided purely by the water column. It was shown 
that when the inner diameter of the airway tube size and the length of the tube is reduced, it resulted 
in a much higher PEP than indicated by the water level alone. Although this was a laboratory study, 
findings were comparable with those concluded in studies investigating Blow Bottle design 
parameters in human subjects (Sehlin et al., 2007; Christensen, Jensen, Schonemann, Petersen, 1995). 
Literature also mentions the adverse effects of the Blow Bottle, which includes pathogens developing 
in the device itself, increased work of breathing during the use of the Blow Bottle, and general safety 
concerns such as risk of aspiration. The device itself may be a possible site for pathogens, as the water 
in the bottle may not be changed regularly (Johnston, James & Mackney, 2013). An incorrectly 
constructed Blow Bottle device may result in a larger positive pressure being produced and therefore 
may lead to increased work of breathing and respiratory muscle fatigue during the use of the Blow 
Bottle (Mestriner et al., 2009). The Blow Bottle may become an electrical safety hazard, should it leak 
or fall over or placed near electrical equipment. As the Blow Bottle contains water, this may be an 
aspiration risk if patients are insufficiently cognitively aware and inadvertently drink the water from 
the container or inhale instead of exhaling during the treatment (Johnston, James & Mackney, 2013).  
In the 1970’s, the PEP mask was introduced, exchanging the water column and tube for a variable 
resistor, mask, and manometer (Sehlin et al., 2007; Fagevik Olsén, Hahn, Nordgren, Lönroth & 
Lundholm, 1997). Commercial PEP devices have since grown to include devices that create 
vibrations during exhalation, and can be classed under the umbrella term Oscillating PEP or OPEP. 
Such devices include the Acapella, Flutter, and Quake (Clini, 2009; Myers, 2007). These PEP devices 
generally showed generating a mean expiratory pressure range of 5-20 cmH2O (Mestriner et al., 2009; 
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Darbee, Ohtake, Grant & Cerny, 2004). Specific prescriptions, that is, the number of repetitions; level 
of the water or amount of PEP employed for the use of the Blow Bottle and PEP devices vary in 
literature. Some asked patients to blow for two sets of ten per hour (Campbell, Ferguson & McKinlay, 
1986); blow for 10 minutes every fourth hour (Heisterberg, Johansen, Larsen, Holm, Andersen, 
1979); five breaths per hour (Hanekom et al., 2012), blow for five minutes per hour (De Pietri, 
Montalti & Begliomini, 2014). Fagevik Olsén (2015) suggested that varied prescription and dosage of 
PEP devices may be required to address different pathologies such as pneumonia versus atelectasis 
(Olsén, Lannefors & Westerdahl, 2015).  
Although the Blow Bottle has evolved, in clinical practise in South Africa, the Blow Bottle is a 
common adjunct to physiotherapy, perhaps as it is easily constructed using inexpensive and accessible 
materials found in most hospitals (Johnston, James & Mackney, 2013; Johansson et al., 2013; Clini, 
2009). 
 
PEP Therapy and Abdominal Surgery: The use of the Blow Bottle  
A recent survey of public hospitals in New South Wales, Australia, reported that manually 
constructed PEP devises such as the Blow Bottle were more commonly used than those commercially 
available. PEP was used primarily in respiratory conditions as a means of secretion clearance, 
treatment, and prevention of alveolar collapse, prevention of complications, and reduction of 
shortness of breath (Johnston, James & Mackney, 2013). The recommended dosage for the use of the 
Blow Bottle post abdominal surgery varies from 3 to 30 blows every hour (Johnston, James & 
Mackney, 2013; Orman & Westerdahl, 2010). Few respondents also reported that they used the PEP 
bottle as a “visual reminder” for patients to do their exercises (Johnston, James & Mackney, 2013). A 
recent Swedish study reported similar results where survey results showed that the Blow Bottle was 
the most common PEP therapy device used in the post-operative management of abdominal surgery 
(Johansson et al., 2013). Orman and Westerdahl (2010) did a systematic review investigating the use 
of PEP therapy after thoracic and abdominal surgery.  
Six articles were included in this review and only one showed any positive effects of PEP when 
compared to other physiotherapy breathing techniques. Of the six articles included in the review, only 
four investigated abdominal surgery and only two of the four evaluated the use of the Blow Bottle, 
which is Heisterberg et al. (1979) and Campbell et al. (1986). In the Heisterberg article, the Blow 
Bottle technique was compared to a bi-daily physiotherapy regime including breathing exercises and 
postural drainage. No significant difference was found between the groups regarding scoring of 
atelectasis. The Campbell study compared a physiotherapy regime to a physiotherapy regime with the 
additional use of the Blow Bottle. Results showed that there was no significant improvement 
regarding post-operative pulmonary complications. When compared to conventional physiotherapy, 
the additional use of PEP added no significant benefits. Of the six studies included in this systematic 
review, only one was performed out of Scandinavia. Both studies, which included the use of the Blow 
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Bottle, were published more than 20 years ago, highlighting the lack of recent evidence for the use of 
the Blow Bottle in this field (Orman & Westerdahl, 2010). 
 
 
1.2 Rationale for the study 
Post-operative cardio-respiratory physiotherapy for patients undergoing abdominal surgery has been 
found to be beneficial in improving lung function and the prevention and treatment of PPCs 
(Manzano et al., 2008; Richardson & Sabanathan, 1997). The Blow Bottle PEP device is commonly 
used in the clinical setting perhaps as it is low cost and more easily accessible, as physiotherapists can 
construct it themselves (Johnston, James & Mackney, 2013; Johansson et al., 2013; Clini, 2009). 
However, evidence to support the use of Blow Bottles in the post-operative management of 
abdominal surgery is minimal and outdated, with few studies reporting significant positive effects 
especially when compared to conventional physiotherapy techniques (Orman & Westerdahl, 2010; 
Pasquina et al., 2006; Richardson & Sabanathan, 1997; Hall et al., 1996). Therefore, this study serves 
to investigate the additional use of the Blow Bottle to conventional cardio-respiratory physiotherapy 
to improve patient outcomes, namely, lung function and the development of PPCs. 
 
1.3 Research Question 
How does the addition of the Blow Bottle to conventional post-operative cardio-respiratory 
physiotherapy (a regime of early mobilization and deep breathing exercises) affect post-operative lung 
function as measured by FEV1 and FVC and the development of PPCs? 
 
1.4 Aim of the study 
To investigate the effects of the Blow Bottle as an addition to conventional post-operative cardio-
respiratory physiotherapy on post-operative outcomes and to determine whether the addition of the 
Blow Bottle is more beneficial. 
 
1.5 Objectives of the study 
To determine how the addition of the Blow Bottle to conventional post-operative cardio-respiratory 
physiotherapy affects: 
1. Lung-function (as measured by means of spirometry using the Spirolab™ portable spirometer), forced 
expiratory volume in one second (FEV1), and forced vital capacity (FVC).  
2. The development of PPCs: with PPC defined as 3 or more of the following respiratory signs occurring 
within the same day, in the first 14 days after surgery (Mackay, Ellis & Johnston, 2005): 
• Changes in auscultation (decreased breathe sounds, crackles, wheezes, bronchial breathing)     that 
were additional to those found pre-operatively 
•     Temperature over 38 degrees Celsius  
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•     Chest X-ray changes consistent with collapse, consolidation, or atelectasis 
•      Increase in amount and/or change in colour of sputum produced, compared to what the patient 
reports pre-operatively 
 
1.6 Null Hypothesis 
There is no difference in effects on post-operative outcomes between conventional post-operative 
cardio-respiratory physiotherapy and conventional cardio-respiratory physiotherapy with the 











































In order of appearance: 
PPCs- Post-operative Pulmonary Complications 
PEP- Positive Expiratory Pressure 
FEV1- Forced Expiratory Volume in 1 second 
FVC- Forced Vital Capacity 
A-APODS-Adapted Abdominal Surgery Physiotherapy Outcomes Data Sheet
NRF- National Research Fund 
CPRG- Cardio Pulmonary Rehabilitation Group 
PEEP- Positive End Expiratory Pressure 
GIT- Gastro Intestinal Tract 
HPB- Hepato Biliary 
SATS- South African Thoracic Society 
ATS- American Thoracic Society 
ERS- European Respiratory Society 
APODS- Abdominal Surgery Physiotherapy Outcomes Data Sheet 




All glossary items retrieved using Medline Plus (U.S National Library of Medicine) as obtained from 
https://www.nlm.nih.gov/medlineplus/mplusdictionary.html  in August 2015.  
Laparotomy: Surgical section of the abdominal wall  
Hemicolectomy: Surgical excision of part of the colon 





CHAPTER 2: METHODOLOGY 
 
2.1 Introduction 
This chapter will describe in detail the methodology used to answer the research question. This 
includes a description of the research setting, study design, and participants. Instrumentation, 
procedures, ethical and statistical considerations used to implement and analyse the above will be 
elaborated on below. 
 
2.2 Research Setting 
The primary study was conducted at two private hospitals and one public tertiary hospital within Cape 
Town in the Western Province. The two chosen private hospitals form part of one of the largest 
private hospital networks in South Africa (Life Healthcare Website as accessed on 1 March 2015). 
The study was carried out in their Gastro-intestinal (GIT) Units. The public hospital included in this 
study is one of the leading tertiary academic hospitals in South Africa (Western Cape Government 
Website as accessed on 1 March 2015). The study was conducted specifically within the hospital’s 
Colorectal and Hepatobiliary (HPB) units. This public tertiary institution services the Southern 
Suburbs, Cape Metropolis, and surrounds. Private hospitals, unlike the state hospitals, are not 
restricted to providing their specialized services according to municipal boundaries, with the result 
that patients may be referred from any geographic area, even from neighbouring states or countries. 
 
2.3 Research Design 
The researcher used a single blinded randomized control trial with repeated measures design. 
 
2.4.1 Sample Size  
The ideal sample size was calculated using STATISTICA version 12.5 (www.statssoft.com), which 
calculated that a total number of 74 participants would provide a 90% chance of detecting a large 
effect size for this trial. It was calculated that 37 participants per group were needed if the mean 
predicted FEV1 (L/s) of the control group was at estimated at 69.6 % FEV1 and the mean predicted 





2.5  Participants 
  
2.5.1 Inclusion and exclusion criteria 
 
Inclusion criteria 
Patients were included if they were 18 years of age and older, admitted from home and scheduled to 
undergo elective open abdominal surgery via midline incision. Patients were scheduled for surgery 
and admitted through the Hepatobiliary (HPB), or Colorectal surgical units within the public sector, 
and Gastro-intestinal (GIT) units within the private sector. The decision to include these units is 
because these units typically perform elective open laparotomies via midline incisions. In addition, 
sampling participants exclusively from these units was to ensure that participants with similar 
conditions and surgical requirements were present within the sample group. For purposes of consent, 
participants over the age of 18 years were included. All patients were eligible for inclusion if they 
were orientated to time/person and place and able to communicate in English. This was to ensure that 




Patients already hospitalized and awaiting open abdominal surgery were excluded from the study, as 
these patients may have already been referred for in-patient physiotherapy, which might influence the 
results of the study. Patients fulfilling the inclusion criteria but remained ventilated for longer than 24 
hours directly after elective surgery were excluded, as patients are not routinely ventilated post-
operatively and ventilation and intubation would deem the patient unable to use the Blow Bottle 
treatment. 
 
2.5.2. Sampling Method 
The researcher used a sample of convenience, in that every patient who met the criteria was 
approached for recruitment. 
 
2.5.3. Recruitment of participants 
Ethical approval and institutional approval was obtained from the selected trial sites (see 2.12). The 
institution and surgical teams of the HPB, Colorectal and GIT units relevant to the institution granted 
access to the theatre lists. Names of the patients eligible for the study were extracted from the theatre 
list. Patients undergoing surgery and admitted through these units were routinely admitted the day 
before surgery. Patients on the theatre list were then approached pre-operatively, given an information 
letter, informed about the trial, and asked whether they would like to participate. Further information 
and informed consent was then gained from those patients willing to participate. Thereafter, pre-
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operative details were gathered to establish a baseline. Patients were informed that if they were not 
willing to participate in the trial, their surgical procedures, and post-operative management would 
continue as usual (see page 2.12). The primary researcher carried out this process. 
 
2.5.4. Randomization  
Participants were randomized into two groups: 
1. The control group (CG) receiving conventional post-operative cardio-respiratory physiotherapy 
2. The intervention group (IG) receiving conventional post-operative cardio-respiratory physiotherapy 
with the additional use of the Blow Bottle 
Participants were allocated to the treatment or control group by means of simple randomization, using 
a computer generated random number process to allocate the participants to either the control or 
treatment group (www.randomization.com) (see 2.8.2). 
 
2.6. Description of Conventional Group and Intervention Group Regimes 
 
2.6.1. Conventional Cardio-respiratory Physiotherapy 
Both groups (CG and IG) received conventional post-operative cardio-physiotherapy. Conventional 
cardio-respiratory physiotherapy included breathing exercises inclusive of non-PEP breathing devices, 
manual chest physiotherapy techniques inclusive of a combination of vibration, percussions, 
coughing, and exercises inclusive of general exercise and mobilization. The conventional cardio-
respiratory physiotherapy treatment was conducted a minimum of once daily from Day 1 post-
surgery, and continued till the participant was discharged from hospital or deemed ready to be 
discharged from physiotherapy by the treating physiotherapy team. Readiness for discharge from 
physiotherapy was based on the participants’ ability to mobilize adequately and their chests deemed 
clear (dependent on their ability to clear secretions if any, and no signs of respiratory complications). 
Conventional treatment was carried out as the physiotherapy team deemed appropriate and as per the 
routine practises of the physiotherapy team. The physiotherapist documented the treatment given to 
the participants on the Adapted Abdominal Surgery Physiotherapy Outcomes Data Sheet (A-APODS) 
(see Appendix A). Evaluation by the researcher continued until the participant was discharged from 
physiotherapy. 
 
2.6.2. Intervention Group Therapy 
Participants allocated to the treatment group received conventional cardio-respiratory physiotherapy 
as described above with the additional use of the Blow Bottle during the physiotherapy session. The 
primary researcher constructed the Blow Bottle and filled it with 10cm of water (2.7.1). The 
physiotherapist instructed the participants to use the Blow Bottle by taking a deep inhalation and 
exhaling slowly by blowing bubbles via the tube in the bottle. This was repeated a minimum of 10 
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times during the session. For the purposes of this study, atleast 10 breathes every hour was chosen as 
articles investigating the use of PEP devices varied on the specific dosage of the PEP device 
implemented (Campbell, Ferguson & McKinlay, 1986; Heisterberg et al., 1979; Hanekom et al., 
2012; De Pietri, Montalti & Begliomini, 2014). Therefore, hourly treatment of 10 breathes were used 
as this was observed as common practice. The physiotherapist recorded the resistance and repetitions 
executed during the treatment on the A-APODS (see Appendix A). Participants were encouraged to 
self-administer the device as taught, every waking hour.  
2.7 Measurement instruments  
2.7.1. The Blow Bottle 
The primary researcher constructed the Blow Bottle and gave them to the physiotherapy team of the 
hospital to distribute to participants within the IG. The optimum design for a therapist constructed 
Blow Bottle was shown to comprise of an inner tubing diameter of ≥8mm, an air-space orifice of 
≥8mm, and a water column of 10cm. This generated a pressure of 10cmH2O (Mestriner et al., 2009). 
These specifications were therefore used to construct the Blow Bottles for this trial (see Illustration 1 
& 2). 
Illustration 1: Blow Bottle (front view) 
Inner tubing diameter of 
≥8mm 
Air-space orifice of 
≥8mm 
Instructions: 10 long 
blows every hour (take a 
deep breath in and blow 






Illustration 2: Blow Bottle (rear view) 
 
 
2.7.2. Blow Bottle Logbook 
The primary researcher developed a logbook as a means to record the compliance with the self-
administration of the Blow Bottle. This logbook contained an hourly record of the use of the Blow 
Bottle by the participant and where after a member of the nursing staff who witnessed the participant 
using the Blow Bottle signed it off (see Appendix C). 
2.7.3. Lung Function Testing 
Lung function was chosen as an outcome measure to identify and quantify the participants’ 
pulmonary mechanics. Lung function testing via spirometry proved to be an effective tool to evaluate 
the effectiveness of therapeutic interventions (Kacmarek, Stoller & Heuer, 2013, Egans Fundamentals 
of Respiratory Care, p.400). FEV1 and FVC were therefore chosen as the primary lung function 
parameters. Several studies investigating the abdominal surgical populations use these variables as an 
outcomes measure and have shown that open abdominal surgeries are associated with respiratory 
compromise and reduced lung function post-operatively as evident in reduced measurements of FEV1 
and FVC (von Ungern‐Sternberg, Regli, Schneider, Kunz & Reber, 2004; Hasuki et al., 2002; 
Smetana, 1999; Joris, Kaba & Lamy, 1997). The measurement of other spirometry variables such as 
FRC (Functional Respiratory Capacity) and TLC (Total Lung Capacity), although they provide a 
more accurate measurement of lung function, they are very difficult to measure at the patient’s 
Water column of 10cm 
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bedside, hence re-enforcing the decision to include FEV1 and FVC as the outcomes measures. 
Spirometry variables FEV1 (Forced Expiratory Volume in one second) and FVC (Forced Vital 
Capacity) were recorded. These are typically measured spirometry variables and considered the most 
important aspects of spirometry. FVC pertains to the maximal volume of air the subject is able to 
exhale with maximum effort from an inspiration of maximum capacity. FEV1 pertains to the maximal 
volume of air the subject is able to exhale in the first second of a forced expiration from an inspiration 
of maximum capacity (Miller, Hankinson, Brusasco, Burgos, Casaburi, Coates, Crapo, Enright, 2005).  
The normal values for FVC and FEV1 are expressed as 5L for FVC and 4L for FEV1 as published in 
Egan’s Fundamentals of Respiratory Care, ninth edition (Kacmarek, Stoller & Heuer, 2013; Miller et 
al., 2005). The Spirolab™ colour LCD MIR portable spirometer was used in this study and calculates 
the predicted lung function values for FEV1 and FVC using the ERS (European Respiratory Society) 
predicted values relating to the patients age, gender, height, weight and ethnicity as entered by the 
user. For this study, the option to calculate predicted values without ethnicity was selected. This was 
as the South African population and anticipated sample population is diverse, and literature describing 
standardized predicted value norms for the African population is minimal and absent for the South 
African population (Koegelenberg, Swart & Irusen, 2013; Quanjer, Stanojevic, Cole, Baur, Hall, 
Culver, Enright, Hankinson, 2012). Therefore, to establish changes in lung function the patients’ pre-
operative baseline and predicted spirometric values we measured against those obtained post-
operatively.  
The manufacturer calibrated the Spirolab™ 3-colour LCD MIR portable spirometer prior to the study 
and on two occasions during the course of the study. The manufacturer also checked the software and 
hardware of the device on these occasions. Lung function testing was conducted pre-operatively 
during the initial contact session, and daily post-operatively commencing on Day 1 post-surgery, by 
the primary researcher only, who was blinded to group allocation. Standard procedures for the use of 
spirometry as described by Koegelenberg at al 2013 were adhered. The guidelines by Koegelenberg et 
al. (2013) are representative of the views of the South African Thoracic Society (SATS) and 
incorporate the findings of the American Thoracic Society (ATS) and the European Respiratory 
Society (ERS) (Miller et al., 2005). All spirometry testing were performed with the participant in a 
seated position or an upright position in bed. During the pre-operative session, the spirometry testing 
procedure was explained thoroughly and participants’ were shown how to execute the lung function 
manoeuvres, instructed, and demonstrated by the primary researcher. Participants were instructed as 
follows: participants were asked to inhale completely and rapidly, place the mouthpiece in the mouth 
and seal their lips around the mouthpiece, then exhale maximally until no more air could be expelled. 
On each occasion when spirometry was tested, the participants were again instructed on how to 
execute the manoeuvre. At each measurement time, the participants were asked to perform the 
manoeuvre for the testing for FVC and FEV1. The Spirolab™ 3-colour LCD MIR portable spirometer 
was able to test and display the accuracy and repeatability of the test. A minimum of three attempts 
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and a maximum of eight attempts were performed and the average reading of the three best attempts 
was recorded.  
2.7.4. The Adapted Abdominal Surgery Physiotherapy Outcomes Data Sheet (A-APODS) 
Mackay et al. (2005) in their study investigating physiotherapy in the abdominal surgical population 
used a data sheet to record various outcome measures during their study (Mackay, Ellis & Johnston, 
2005). This data sheet was referred to as the “Abdominal Surgery Physiotherapy Outcomes Data 
Sheet” or “APODS” (see Appendix B). The purpose of the APODS was to record data pertaining to 
the following categories: 
• Pre-operative data: including demographic information, co-morbidities, and pre-operative risk factors.  
• Operative data: including the duration of anaesthesia and intra-operative details. 
• Post-operative data: This included the development of post-operative complications and the type of 
antibiotics and analgesic drugs used. Physiological outcomes such as the development of PPCs and 
mobility outcomes in terms of the restoration of mobility were also recorded. 
• Staffing details: Employment and experience of the treating physiotherapists. 
 
Mackay et al. (2002) first developed the APODS instrument and tested the reliability and validity of 
the instrument. The APODS demonstrated good content and predictive validity and high intra-rater 
and inter-rater reliability. The APODS obtained a Kappa co-efficient range from k=0.64-1.00 
indicating substantial intra-rater reliability. The inter-rater reliability Kappa statistic ranged from 
k=0.69-1.00 indicating substantial agreement in the majority of the data categories. In terms of 
predictive validity, the APODS showed a 2% chance of indicating a false positive in diagnosing the 
development of a PPC, and 0% chance of finding a false negative result. The information regarding 
the reliability testing and development of the APODS was gathered from the two articles Mackay 
(2003) and Mackay et al. (2005), as well as from personal communication with the author, and 
unpublished documentation acquired from her (Mackay MR, 2003). 
 
Development of the A-APODS 
The APODS was quite long (three pages long) and would have required extensive time for busy 
clinicians in a resource constrained environment like South Africa to complete, the APODS was 
therefore condensed. The APODS was condensed into a 2-page document that comprised of the most 
important categories relevant to the study. This document was then referred to as the Adapted 
Abdominal Surgery Physiotherapy Outcomes Data Sheet or A-APODS (see Appendix A). All the key 
categories in the APODS were kept, with the exception of the intra-operative and staffing details, as 
some details within these categories recorded in the APODS were observed to not be typically 
recorded in South African hospital institutions (both private and public). For example, the APODS 
documented details regarding the intraperitoneal sepsis during the time of the surgery and the 
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American Society of Anaesthesiologists’ classification of physical status (ASA) score. These were 
therefore omitted. In addition, a category for the recording of the physiotherapy treatment given and 
the use of the Blow Bottle was added.  
 
Content Validity of the A-APODS 
The first draft of the A-APODS document was circulated amongst three physiotherapists with 
expertise in the field of cardio-respiratory physiotherapy. Each physiotherapist selected to review the 
A-APODS document were either in senior physiotherapy or lecturing positions and had a minimum of 
20 years’ experience in physiotherapy. The physiotherapists were requested to give written or verbal 
feedback as to the content of the data sheet, the readability of the document, and any additional 
information that they regarded necessary to remove or insert into this document. Their input indicated 
the need to change the document from a scoring system used in the APODS to a tick system, as it 
would be easier to complete in practise (see Appendix B). All agreed that the data recorded on the 
document, however detailed, was comparable to what may be recorded by a physiotherapist during 
usual physiotherapy practice.  
A second draft of the A-APODS with the necessary amendments was then circulated amongst the 
physiotherapy teams at the selected sites for the randomized control trial, requesting feedback 
regarding the feasibility of completing the document on a daily basis. The physiotherapy teams 
suggested that the document be bound to allow for ease of transportation during treatment rounds. 
This suggestion was acknowledged and implemented. The reliability of the A-APODS was then 
evaluated during the Pilot study.  
 
2.8 Research Procedures 
This section elaborates on the training of staff and research personnel, followed by the blinding and 
randomization procedures employed. The pilot study and findings will also be described. The primary 
aspect of this section is the data collection procedure and will be described in detail.  
 
2.8.1. Training of staff and research personnel 
 
Physiotherapists 
Prior to the commencement of the trial, the primary researcher met with the physiotherapy teams of 
the respective institutions. The procedures were then discussed and the role of the physiotherapists 
during the trial explained. The physiotherapists were all taught how to use the Blow Bottle and how to 
instruct participants to use the device. The randomization procedure and its implementation were also 
explained. The logbook, to measure compliance for use of the Blow Bottle was discussed and the 
physiotherapists asked to distribute it when the participants were given their Blow Bottle. The 
physiotherapists were also briefed on how to complete the A-APODS and notified that data needed to 
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be collected daily and only returned to the primary researcher once the participant had been 
discharged from physiotherapy. 
 
Research personnel 
Research personnel were employed to assist with the blinding procedure. Since the primary researcher 
was blinded as to which group the participants were allocated to, they were briefed to remove all 
evidence of the participants’ group allocation such as the Blow Bottle and logbook prior to the 
primary researcher coming to conduct the participants’ spirometry readings. The research personnel 
also assisted in returning the Blow Bottle and logbook to the participant after the primary researcher 
had left the unit. 
 
Nursing staff 
The nursing staff was informed about the trial and the procedures involved. They were introduced to 
the research team. The Blow Bottle, including its background, use and implementation was explained 
to the nursing staff. They were informed that the participants allocated to the Blow Bottle group need 
to use the Blow Bottle at least 10 times every hour. The nursing staff was also taught how to use the 
Blow Bottle, by blowing out into the tube as long as possible but not till all the air is expelled out of 
the lungs. They were informed that the physiotherapist would instruct the participant on how to use 
the Blow Bottle and implement the use of the device during the physiotherapy session. The nursing 
staff were requested to encourage participants and assist participants, if necessary, to use the Blow 
Bottle every hour. They were also asked to assists participants with the self-administration of the 
Blow Bottle device and ensure participants comply by using the logbook and signing it after use (see 
Appendix C). 
 
2.8.2. Randomization Procedure 
As a first step, the primary researcher generated a list of successive numbers that would be assigned to 
consecutive participants. These numbers were then entered into the randomization website 
(www.randomization.com ). This website allows for a computer generated randomization programme 
that assigned these successive numbers arbitrarily to either the CG or IG. The randomization process 
allows each printed document to contain a different randomized allocation, generating several 
versions of the allocation process. This was printed out on several sheets that were given to the 
physiotherapy teams of the various institutions. They then selected at random which sheet they would 





The researcher used a single blinded protocol. The computer generated randomization process was 
concealed to the primary researcher. The primary researcher only became aware of the participant’s 
group allocation once the participant was discharged from physiotherapy and exited the trial. In 
addition, as the researcher conducted the lung function spirometry testing, research assistants were 
employed to ensure the blinding procedure was followed daily. They were set with the task of 
removing the Blow Bottle and logbook prior to the primary researcher coming to conduct the 
participants’ spirometry readings and returning it once the primary researcher had left the unit. As 
outcomes were recorded on the A-APODS, this document was only returned to the primary researcher 
once the participant had been discharged from physiotherapy. This was to ensure that the primary 
research remained blinded during the data collection process. 
2.8.4. Pilot Study 
The primary aims of the pilot study was to evaluate how the physiotherapists were able to implement 
the Blow Bottle intervention and record the data necessary to complete the A-APODS. The pilot study 
was conducted at a private hospital in the Southern Suburbs forming part of the sixth largest private 
hospital group in the world (Constantiaberg Medi-Clinic Website as accessed on 1 March 2015). The 
researcher chose this institution due to its convenience and accessibility to the primary researcher. 
Ethical approval was received for this study and verbal approvals from the hospital and nursing 
management as well as physiotherapy teams were received prior to the commencement of the pilot 
study. All patients admitted for any open abdominal surgery were eligible for the trial. All participants 
were included as per the inclusion and exclusion criteria (see 2.5.1). The pilot study therefore 
included a sample size of 13 participants. This pilot phase ran over a 3-month period from 01 
November 2013 until 30 January 2014.  
Pilot Study Findings 
The pilot study served to ascertain the efficacy of the data collection process, the intervention, as well 
as the reliability of the A-APODS. The physiotherapy team consisted of four physiotherapists. Using 
the A-APODS, the treating physiotherapists were able to extract the relevant data from the medical 
records. The physiotherapists reported that recording the use of the Blow Bottle and the physiotherapy 
treatment given was easy and not labour intensive. As the patients may be treated by a variety of 
physiotherapists during their duration of hospitalization, as no patient is treated exclusively by one 
physiotherapist, it was observed that most physiotherapists were able to record majority of the 
information. The physiotherapists were able to implement the use of the Blow Bottle into their 
physiotherapy regime with ease. The participants were able to use the Blow Bottle during the 
physiotherapy sessions and verbally reported that they used the Blow Bottle in between sessions 
without the assistance of the physiotherapy team. The A-APODS showed to reproduce results in 
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agreement between the treating physiotherapists. Very little missing data was observed and the 
physiotherapists reported that the data sheet was straightforward and easy to complete.  
2.9 Collection Procedure 
 
Drawing from the pilot study and the procedures previously explained, the data collection procedure 
for the primary trial was developed. The data collection process will be explained in detail below, 
followed by a flow diagram representing the key elements of the data collection process. The data 
collection procedure was therefore as follows: 
Patients were recruited the day before their scheduled surgery. Consenting participants were then 
enrolled into the study (see 2.12). During the pre-operative consultation, baseline information was 
recorded and the pre-operative spirometry measurements done by the primary researcher. This 
baseline information was then forwarded to the physiotherapy teams. Participants were then randomly 
allocated to either the CG or IG by means of a computer generated randomization process as 
previously described (see 2.8.2). Participants then underwent their scheduled surgery after which 
physiotherapy commenced on the first post-operative day. Physiotherapy as per the CG and IG 
intervention programmes then continued daily until the participants were deemed fit for discharge 
from physiotherapy, that is, they were assessed to be able to clear secretions effectively and were able 
to mobilize adequately.  
All post-operative outcomes such as temperature, auscultation findings, imaging investigations (chest 
x-rays or CT scans), sputum, as well as the Blow Bottle and physiotherapy treatment were 
documented by the physiotherapy team per treatment session on the A-APODS (see Appendix A) . 
The primary researcher conducted spirometry measurements on a daily basis. The blinding procedure 
as described previously were adhered to during the study with research personnel ensuring that 
evidence of group allocation would be concealed to the primary researcher (see 2.8.3). The 
physiotherapy team kept the A-APODS data sheet, brought it to each physiotherapy session for 
completion, and returned it to the primary researcher for analysis after the participant exited the trial. 






























Figure 1: Data Collection Procedure Flow Diagram 
2.10 Data Management 
The physiotherapy teams kept all A-APODS documents securely in a locked cupboard in their offices. 
The A-APODS documents were then returned to the primary researcher after the participant had been 
discharged and were safely stored during the data analysis process.  
 
2.11 Statistical Analysis 
Data was analysed using STATISTICA version 12.5 (www.statssoft.com). Data was analysed in 
relation to specific objectives. To assess the effects on lung function parameters, the effect of 
Patients recruited pre-operatively 
and consenting participants 
enrolled into the study 
Baseline information obtained and 
spirometry testing conducted by 
the primary researcher during the 
pre-operative session 
Surgery performed 
Participants assigned to either the 
CG or IG by the physiotherapy team 
using the randomization sheet 
Control group (CG) Intervention Group (IG) 
Conventional cardio-respiratory 
physiotherapy given (and 
recorded on the A-APODS) 
Conventional cardio-respiratory 
physiotherapy given with the 
additional use of the Blow Bottle 
(and recorded on the A-APODS) 
Spirometry testing conducted Spirometry testing conducted 
Participants discharged from the trial once deemed fit for discharge from physiotherapy by 
the physiotherapy team 
A-APODS returned to the primary 
researcher for analysis 
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randomized treatment (CG vs. IG) and time (Day of treatment) on FEV1 and FVC of participants were 
analysed using repeated measures ANOVAs, followed by post-hoc Tukey tests. The development of 
PPCs is a composite outcome measure (that is, made up of several variables such as changes in 
auscultation, imaging, temperature, and sputum analysis). These categorical variables were analysed 
using a two-way Chi-squared test with Yates correction factor applied for low cell counts. A sub-
analysis of the four individual categorical variables making up the composite outcome of PPC was 
similarly analysed using two-way Chi-squared tests. To do so, outcome measures were considered as 
binary events (yes/no) when differences from their pre-operative measures were noted; for example, 
on an individual level an auscultation was described as present (yes) when any post-operative measure 
of auscultations was noted as different from normal breath sounds observed pre-operatively. 
Assumptions for parametric statistical tests were investigated by means of P-plots (normality) and 
Levene’s test (homogeneity of variance). 
 
2.12 Ethical Considerations 
Ethical approval was received from the University of Cape Town through the Health Sciences Human 
Research Facility, HREF: 493/2013 (see Appendix D). Ethical approval was then renewed in 2014 
(see Appendix E). Institutional approval was received from each institution involved in either the pilot 
or the primary trial. The private institutions used for the primary trial were constituents of the same 
network of hospitals. Written approval to conduct the primary trial within this network was received 
(see Appendix F). This approval letter was then presented to the hospital and nursing management 
teams of the respective institutions, who gave verbal approval to conduct the trial within their 
facilities. Approval from the public tertiary hospital was also received (see Appendix G). The 
researcher discussed the trial and expectations with the hospital management, nursing management, 
surgeons, and physiotherapy teams, and each gave verbal approval to conduct the study and agreed to 
assist where necessary.  
This section will briefly describe various aspects for ethical consideration associated with the study 
including autonomy, beneficence, non-maleficence, confidentiality, justice, and the related risks and 
benefits. Informed consent will be elaborated on and described below. 
Autonomy 
Patients were approached pre-operatively the day before surgery and the trial and all procedures 
discussed.  Participants were given the opportunity to ask questions and clarify information and given 
time for participants to refuse treatment. Patients were informed that if they were not willing to 
participate in the trial, their surgical procedures, and post-operative management would continue as 





Each participant received the routine care of the specific institution, which was conventional cardio-
respiratory physiotherapy. The treatment group had their physiotherapy treatment supplemented with 




Each participant received routine conventional cardio-respiratory physiotherapy as per normal 
practices of each institution. 
 
Confidentiality 
All data was recorded with anonymity by assigning each participant to a coded reference number. 
 
Justice 
The IG received the Blow Bottle device. Literature mentions the benefits of the use of this device, but 
no clear evidence to its superiority over physiotherapy techniques alone were established, especially 
in this population. Both groups received conventional cardio-respiratory physiotherapy as it was part 
of routine hospital practise, and research made evident the benefits of cardio-respiratory 
physiotherapy techniques such as deep breathing exercises and early mobilization, and both groups 
benefitted from the inclusion of these practises. 
 
Risks and Benefits 
Risk for participant: Participants were informed that they would not receive any monetary payment 
for their participation in the trial. An additional 20 minutes was necessary to complete the pre-
operative session to gain baseline information. Participants allocated to the treatment group also 
received a logbook and asked to self-administer the device and complete the Blow Bottle logbook. An 
additional five minutes was required to obtain spirometry readings daily. Participants were made 
aware of the risk that spirometry testing might result in some exhaustion, as it required the participant 
to breathe deeply and exhale rapidly. Once participants were able to mobilize adequately and their 
chests were clear (ability to clear secretions if any, and no signs of respiratory complications), the 
physiotherapist assessed the participant and discharged them from physiotherapy. Evaluation by the 
researcher continued until the patient was discharged from physiotherapy. Participants were made 
aware of these points within the information sheet and verbal discussion. 
Informed Consent 
When patients were approached pre-operatively, they were given an information letter and asked 
whether or not they would like to participate in the trial (see Appendix H). The information sheet 
informed the patient of the study and explained that refusing to participate in the study, would not 
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affect the treatment they receive in hospital or the routine post-operative cardio-respiratory 
physiotherapy treatment they received. Only consenting participants were included in the trial. During 
the pre-operative session, the research personnel obtained written informed consent (see Appendix I). 
Approaching the participants pre-operatively was to ensure that the participant was not under duress. 
Verbal consent remained continuous throughout their participation in the trial. 
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CHAPTER 3: RESULTS 
3.1 Introduction 
This chapter will describe the profile as well as the outcomes obtained from the total population 
sampled. The trial initially commenced within the private sector. Despite the inclusion of two private 
hospitals, no eligible participants were recruited and enrolled from these facilities as no participants 
met the inclusion criteria during the period of 01 April to 30 June 2014. The results are therefore 
representative of the population sampled from the public tertiary institution for the period of August 
to November 2014. This chapter will first report on demographic data, followed by results pertaining 
to the two objectives previously described in the introduction, which were the effects on lung function 
and the development of PPCs.  
3.2 Demographic data of the total sample 
The researcher recruited 24 participants who met the inclusion criteria and were eligible for the trial 
from the public tertiary institution. Of the 24 participants recruited, five participants were excluded 
(four participants were excluded as their surgeries were cancelled and one participant was excluded as 
they remained ventilated for more than 24 hours after surgery), thus leaving a total sample of 19 
participants for analysis. All participants underwent general anaesthesia and midline open abdominal 
surgery. However, the exact duration of surgery and anaesthesia was not recorded on the A-APODS. 
The median age in years of participants was 53, with a wide age spread from 25 to 84 years. The 
majority of participants were female (n=14). More than half of the population (n=10) had a history of 
hypertension and six participants were smokers. Notably, the majority of participants n=15 (79%) 
were previously admitted for abdominal surgery and approximately half of the total population (n=9) 
were admitted to have surgery due to cancer. Participants stayed a median of eight days in hospital (as 
calculated from admission the day prior to surgery) and had a median of four post-operative cardio 
respiratory sessions (see Table 2). Results depicted that the majority of participants remained for the 
first and second post-operative days (n=19). Thereafter, participants exited the trial as they were 
discharged from cardio-respiratory physiotherapy, with 16 participants remaining a third post-




Table 2: Descriptive statistics for the study sample (n=19) 
 
3.2.1. Description of the Control Group (CG) and Intervention Group (IG) 
Participants were randomized into the CG and IG, resulting in a CG consisting of 11 participants and 
an IG of 8 participants. The median age of the respective groups was 48 years (CG) and 59 years (IG). 
Despite the dissimilarity in median age between the CG and IG, no statistically significant difference 
(p>0.05) was found. There were more females in the CG (n=9) compared to five in the IG. A large 
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percentage of the total population had hypertension but was equally spread across the CG and IG. Six 
participants were smokers, two in the CG and four in the IG. Participants in the CG stayed a median 
of eight days in hospital compared to the median of 10 days spent by the participants in the IG. 
Although the median length of stay was slightly longer in the IG, this was found not to be statistically 
significant. The median range of hospital stay varied between the CG and IG (5-34 days in the CG 
compared to 6-20 days in the IG). Although the median range of hospital stay was wider in the CG 
compared to the IG, this too was found not to be statistically significant. Both the CG and IG received 
conventional post-operative physiotherapy consisting of a combination of deep breathing exercises, 
manual techniques, and mobilization. The participants in the IG received the additional use of the 
Blow Bottle. Participants used the Blow Bottle a minimum of ten repetitions during the physiotherapy 
session as recorded by the treating physiotherapists using the A-APODS. The Blow Bottle logbook 
was used to record the compliance with the use of the Blow Bottle outside of the physiotherapy 
session. However, this was poorly adhered to during the study, with only one logbook partially 
completed. Participants were discharged from physiotherapy once they were able to mobilize 
independently and their lungs deemed clear.  
When looking at the restoration of mobility scoring across the first three post-operative days as 
recorded on the A-APODS, the following was evident (Table 3): On the first post-operative day, 11 
participants (six in the CG and five in the IG), were unable to mobilize out of bed on the first post-
operative day. By the second post-operative day, four participants in the CG were unable to mobilize 
out of bed, but a larger proportion of participants across CG and IG were able to mobilize with 
standby assistance or independently. By the third post-operative day, three participants were 
discharged from physiotherapy and majority of the remaining participants were mobile. Reasons for 
inability to mobilize were however not recorded. Participants in the CG received a median of three 
cardio-respiratory physiotherapy sessions compared to a median of four sessions received by the IG. 
The range of cardio-respiratory physiotherapy sessions received across the CG and IG was 
widespread, but did not vary considerably between groups with a median range of 2-12 sessions 
received across the CG and 2-15 sessions across the IG. The ratio of participants in the CG and IG 
remained relatively even across the duration of the study despite the dropout ratio. However, as 
majority of the participants only remained for the first three post-operative days, comparative analyses 
across the CG and IG were conducted for a period commencing pre-operatively and across the first 









Table 3: Mobility indicators for the CG and IG across the first three post-operative days 
 
 
3.3 Lung Function for the Control Group (CG) and Intervention Group (IG) 
 
Lung Function parameters FEV1 and FVC were recorded across both CG and IG. The median 
predicted FEV1 and FVC values were comparable to the median pre-operative FEV1 and FVC 
recorded across both CG and IG. Interestingly, although not statistically significant, the median FVC 
values measured for the IG seemed to drop from day-to-day across the first three post-operative days. 
The same trend was not evident across the CG (see Table 4). In both groups, the median FEV1 
showed marginal improvements post-operatively but did not significantly differ across groups. 
Therefore, the improvements in lung function could not be owed specifically to the additional use of 
the Blow Bottle in the IG. Specific lung function measurements obtained by participants were further 
analysed and are described below for the CG and IG. 
Table 4: Summary of Lung Function data 
 
3.3.1. Lung Function findings for the Control Group (CG) 
 
Lung function measurements were obtained pre-operatively for the CG (n=11). There was missing 
data across FEV1 and FVC post operatively. The missing data were due to participants’ inability to 
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perform the manoeuvre required to conduct the spirometry testing because they were either drowsy or 
hindered by nausea or pain. Findings revealed that there was a statistically significant (p<0.05) drop 
in both FEV1 and FVC measurements obtained pre-operatively and post-operatively. However, lung 
function parameters seemed to increase incrementally across the first three post-operative days, 
except for three participants whose lung function measurements for both FEV1 and FVC dropped 
across the post-operative period. Tables 5 and 6 depict these findings where participants who 
exhibited a decline in lung function measurements are highlighted. 
 
 
Table 5: CG FVC pre-operatively and across the first three post-operative days 
 
 Pre-operative: n=11 Day 1: n=9 Day 2: n=11 Day 3: n=9 
CG 
(n=11) 
Predicted FVC Pre-operative: 
FVC 
% of Predicted 
FVC 
FVC % of Pre-
operative FVC 
 FVC % of Pre-
operative FVC 
FVC % of Pre-
operative FVC 
1 2.4 2.91 121% 0.85 35% 0.55 23% 0.45 19% 
2 1.77 2.69 152% 2.04 115% 1.23 69% 3.04 172% 
3 2.82 2.35 83% 0.76 27% 1.12 40% Discharged Discharged 
4 3.91 2.85 73% 1.08 28% 1.51 39% Discharged Discharged 
5 2.73 3.57 131% 0.61 22% 0.94 34% 1.28 47% 
6 4.59 3.16 69% Missing Missing 1.48 32% 2.14 47% 
7 3.25 3.8 117% 2.26 70% 3.12 96% 1.97 61% 
8 3.33 4.51 135% 1.63 49% 2.23 67% 2.42 73% 
9 2.92 2.36 81% 1.72 59% 1.92 66% 1.6 55% 
10 3.11 3.05 98% 0.73 23% 1.44 46% 1.54 50% 












Table 6: CG FEV1 pre-operatively and across the first three post-operative days 
 









FEV1 % of Pre-
operative FEV1 
FEV1 % of Pre-
operative of 
FEV1 
FEV1 % of Pre-
operative FEV1 
1 2.82 2.58 91% 0.75 27% 0.55 20% 0.45 16% 
2 1.43 2.32 162% 0.88 62% 1.15 80% 1.54 108% 
3 2.4 2.34 98% 0.75 31% 1.05 44% Discharged Discharged 
4 3.14 2.33 74% 0.98 31% 1.11 35% Discharged Discharged 
5 2.29 2.79 122% 0.44 19% 0.62 27% 1.22 53% 
6 3.86 2.73 71% Missing Missing 1.18 31% 1.89 49% 
7 2.82 3.13 111% 1.7 60% 2.03 72% 1.77 63% 
8 2.87 2.82 98% 1.26 44% 1.44 50% 1.64 57% 
9 2.52 1.73 69% 1.16 46% 1.37 54% 1.13 45% 
10 2.7 2.56 95% 0.64 24% 1.12 41% 1.31 49% 
11 2.1 2.12 101% Missing Missing 0.53 25% 1.31 62% 
 
3.3.2. Lung Function findings for Intervention Group (IG) 
 
Lung function measurements were obtained pre-operatively for the IG (n=8). The predicted lung 
function parameters were similar to those obtained pre-operatively except for participant one who 
only obtained 40% of the predicted FVC and 47% of the predicted FEV1. As for the CG, missing data 
was evident as participants were either drowsy, nauseous or in pain. Similar to the CG, findings 
revealed that there was a statistically significant (p<0.05) drop in both FEV1 and FVC measurements 
obtained pre-operatively and post-operatively. Generally, lung function parameters seemed to increase 
incrementally across the first three post-operative days; however, more participants in the IG seemed 
to show a drop in post-operative lung function parameters. Four participants exhibited a drop in post-
operative FVC measurements and three a drop in FEV1 measurements. Tables 7 and 8 depict these 
findings where participants who exhibited a decline in lung function measurements are highlighted. 
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Table 7: IG FVC pre-operatively and across the first three post-operative days
Pre-operative: n=8 Day 1: n=7 Day 2: n=7 Day 3: n=6 
IG (n=8) Predicted FVC Pre-
operative: 
FVC
% of Predicted 
FVC
FVC % of Pre-
operative FVC
FVC % of Pre-
operative FVC
FVC % of Pre-
operative FVC
1 2.75 1.11 40% 1.11 40% 1.72 63% 1.3 47% 
2 2.72 3.41 125% 2.29 84% 1.74 64% 2.02 74% 
3 4.15 3.56 86% 2.45 59% 2.19 53% 1.69 41% 
4 3.32 3.07 92% 1.61 48% 1.48 45% 2.14 64% 
5 4.9 4.98 102% 2.91 59% 2.47 50% 1.08 22% 
6 2.63 3.26 124% 2.49 95% 3.04 116% Discharged Discharged 
7 2.18 3.11 143% 1.16 53% 1.99 91% 0.63 29% 
8 2.82 2.68 95% Missing Missing Missing Missing Missing Missing 
Table 8: IG FEV1 pre-operatively and over the first three post-operative days 
Pre-operative: n=8 Day 1: n=7 Day 2: n=7 Day 3: n=6 





% of Predicted 
FEV1
FEV1 % of Pre-
operative FEV1
FEV1 % of Pre-
operative FEV1
FEV1 % of Pre-
operative FEV1
1 2.11 1 47% 1 47% 1.37 65% 1.09 52% 
2 2.32 2.71 117% 2.07 89% 1.62 70% 1.83 79% 
3 3.19 2.92 92% 2.22 70% 1.93 61% 1.42 45% 
4 2.65 3.81 144% 0.79 30% 1.25 47% 1.99 75% 
5 3.93 3.62 92% 0.96 24% 0.9 23% 1.68 43% 
6 2.23 2.55 114% 1.28 57% 2.16 97% Discharged Discharged 
7 1.54 2.7 175% 1.15 75% 1.36 88% 0.63 41% 
8 2.39 2.43 102% Missing Missing Missing Missing Missing Missing 
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3.3.3. Lung Function findings across groups 
 
Data for lung function parameters (FEV1 & FVC) was found to be normally distributed as 
investigated using P-plots and no difference in variance between CG and IG was found using the 
Levene’s test. Lung function parameters were analysed using the ANOVA and post-hoc Tukey 
analysis for differences across the CG and IG pre-operatively as well as over the first three post-
operative days. No significant difference between the CG and IG (n=19) in terms of FEV1 and FVC 
across the pre-operative and post-operative days was found. As previously described, a significant 
difference (p<0.05) between pre-operative and post-operative FEV1 and FVC was found across both 
the CG and IG (n=19). These findings are graphically depicted below in Figure 2 for FEV1 and Figure 
3 for FVC.   
 
Figure 2: Forced Expiratory Volume in 1 second (FEV1) of 19 participants plotted as means with standard deviation 
across randomization group (IG versus CG) with the effect of time illustrated within the key. The only statistical 
differences recorded were between pre-operative and post-operative measures (ANOVA, p<0.05), with no effect of 
randomisation. 
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Figure 3: Forced Vital Capacity (FVC) of 19 participants plotted as means with standard deviation across 
randomization group (IG versus CG) with the effect of time illustrated within the key. The only statistical differences 
recorded were between pre-operative and post-operative measures (ANOVA, p<0.05), with no effect of 
randomisation.  
3.4 Post-operative Pulmonary Complications (PPCs) 
The criteria for the development of PPCs by Mackay et al. (2005) used for this study necessitated that 
three or more changes of the four variables auscultation, temperature, X-rays, and sputum were to be 
present on the same post-operative day in order to diagnose a PPC. No participant had three or more 
of the variables defined on any one day during the study, hence no participant was described as 
having developed a PPC according to the above criteria. Sub-analysis of the composite variables was 
therefore undertaken to investigate changes for each variable component of PPC. Pre-operatively, all 
participants (n=19) had normal breath sounds on auscultation, normal temperature, normal X-rays, 
and no sputum. Post-operative findings were recorded using the A-APODS and will be further 
described for each composite variable across the groups.  
3.4.1. Auscultation 
The A-APODS describes auscultation in terms of four categories: normal breath sounds, decreased 
breath sounds, minimal crepitation and wheezes, and widespread crepitation and wheezes. Majority of 
participants (n=16) across both groups had decreased breath sounds on the first post-operative day, 
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which improved over the first three post-operative days. One participant in the CG developed minimal 
crepitation and wheezes on the second post-operative day. However, across the duration of the study, 
two participants (one each from CG and IG) developed widespread crepitation and wheezes by the 
fifth post-operative day. The participant in the CG improved thereafter and had normal breath sounds 
by the seventh post-operative day. The participant in the IG improved less rapidly and only had 
normal breath sounds by the 13th post-operative day. 
3.4.2. Temperature 
The A-APODS classifies pyrexia when body temperature is greater than 38˚C. On the first post-
operative day, one participant from the IG developed a temperature greater than 38˚C. One participant 
from the CG developed a temperature greater than 38˚C on the second post-operative day. Across the 
duration of the study, the two above-mentioned participants spiked temperatures again by the eighth 
post-operative day.  
3.4.3. X-ray Changes 
Participants did not have routine daily Chest X-rays, but were rather referred for further imaging 
investigations, either chest X-Ray or CT, if they became symptomatic. Two participants in the CG 
developed PPCs diagnosed on CT scan; pleural effusion with atelectasis and bibasilar atelectasis with 
pneumonia on day two and day five respectively. One participant in the IG developed right basal 
atelectasis on the fifth post-operative day.  
3.4.4. Sputum 
The A-APODS describes sputum changes in terms of four categories: no sputum, small amount (1-2 
tsp), moderate amount (up to ¼ cup), and large amount (greater than ¼ cup). No participant in the CG 
or the IG reported any sputum changes from their pre-operative findings over the first three post-
operative days. One participant in the IG developed sputum changes on the fourth post-operative day, 
producing a small amount of purulent sputum. This increased to a moderate amount on the fifth post-
operative day and a large amount by the sixth post-operative day. These sputum findings only 
dissipated by the twelfth post-operative day. No other participant exhibited sputum changes for the 
duration of their hospital stay.  
3.4.5. Summary of Composite PPC findings 
Overall changes in the composite PPC variables from the pre-operative findings were summarized 
and classified as either being present (yes) or not present (no). This was measured across both CG and 
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IG for the duration of the study. For example, if a participant exhibited any changes in auscultation 
findings during the study, this would be depicted as a “yes”. Changes from pre-operative findings 
were analysed using the Chi-squared test and are depicted graphically in the histogram below (Figure 
4). There was no significant difference in findings in each variable between the CG and IG. As 
previously described, majority of both the CG and IG exhibited changes in auscultation findings 
relative to pre-operative auscultation findings. Two participants exhibited temperature changes above 
38˚C. Three were referred for investigative imaging which reported pneumonia and atelectasis, and 
exhibited changes in sputum relative to pre-operative findings. The three participants, who were 
referred for investigative imaging, were the same participants who either had changes observed in one 
of the following, auscultation, temperature, or sputum. None of the participants had three or more of 
the four aspects occurring simultaneously within the same post-operative day as per the criteria for the 
development of PPCs by Mackey et al. (2005). 
 
Figure 4: Changes from the pre-operative findings being present (yes) or not present (no) across composite variables 
of PPC (auscultation, imaging, temperature, and sputum) for CG and IG across the duration of the study. 
3.5 Summary of Results 
 
The total sample obtained (n=19) were majority female, with a wide age range, commonly presented 
with HPT as comorbid disease, and were admitted previously for abdominal surgery. Reasons for 
current surgery related to various cancers (see Table 2). Participants received a median of four 
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physiotherapy sessions and stayed a median of eight days in hospital. Although participants verbally 
said they used the Blow Bottle outside of the physiotherapy session, there was poor adherence to the 
use of the Logbook. Majority of participants were unable to mobilize out of bed on the first post-
operative day, but progressed daily and were independently mobile by discharge from physiotherapy. 
Predicted lung function parameters were comparable to the pre-operative lung function parameters 
measured across both CG and IG. Only one patient in the IG presented with low FEV1 and FVC pre-
operatively, all other patients predicted lung function parameters. No significant difference between 
the CG and IG in terms of FEV1 and FVC was observed across both pre-operative and post-operative 
days. However, a significant difference between pre-operative and post-operative FEV1 and FVC was 
found across both groups. None of the participants developed a PPC according to the composite PPC 
criteria. However, on sub-analysis of each composite variable, participants across both the CG and IG 
exhibited changes in auscultation findings relative to the pre-operative auscultation findings. Notably, 




CHAPTER 4: DISCUSSION 
4.1 Introduction 
This single blinded randomized control trial investigated the use of the Blow Bottle as an adjunct to 
cardio-respiratory physiotherapy in the post-abdominal surgical population, within institutions in the 
Western Cape. This chapter will discuss the findings within the context of current literature in relation 
to the selected objectives:  
• Demographic information 
• Lung function 
• Post-operative pulmonary complications 
4.2 Demographics 
The median age of the study population was 53 years of age. Studies show that patients over the age 
of 59 years, who are admitted for surgery, are considered high risk for the development of PPCs 
(Silva, Li & Rickard, 2012; Mackay, Ellis & Johnston, 2005). Specifically, participants in the IG 
(n=8) were older than those in the CG (n=11), with an age range of  45 to 84 years, compared to 25 to 
68 years in the CG, which places the IG closer to the high risk category. Age has been considered a 
risk factor for the development of PPCs, as the natural progression of the body leads to decreased 
perfusion and oxygenation of the tissue, decreased elasticity of the lung tissue, and increased rigidity 
of the chest wall (Kanonidou & Karystianou, 2007; Sprung, Gajic & Warner, 2006). These factors 
lead to poor lung compliance and reduced lung function due to the reduced pulmonary compliance 
(Kanonidou & Karystianou, 2007). However, in the study by Smetana (1999) who evaluated pre-
operative pulmonary function found that age alone was not a determinant factor for the development 
of PPCs but rather the presence of co-morbidities such as COPD, cardiac disease, diabetes, high 
cholesterol, and hypertension (Smetana, 1999). Co-morbidities are more frequent within the elderly, 
although the overall health of the patient independent of age is considered when determining whether 
the patient will be able to successfully undergo surgery (Canet & Mazo, 2010; Smetana, 1999). 
Although not statistically significant (p> 0.05), having older patients in the IG could have impacted 
on their post-operative recovery and outcomes of lung function and the development of PPCs. Due to 
the small sample size of this current study, correlations with age and development of PPCs were not 
ascertained, as the study lacked power. Co-morbidities in the current study ranged from hypertension, 
previous abdominal surgery, and cancer. Although not matched from the outset of the study for co-
morbidities, the CG and IG had similar co-morbidity profiles. Studies investigating pre-operative risk 
factors in patients scheduled to undergo abdominal surgery, rated patients with more than one co-
morbidity at higher risk for the development of PPCs (Hal et al., 1991). Regarding gender, the 
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majority participants were female as seen in demographic data depicted in Table 2 (refer 3.2). These 
findings are in keeping with the scant literature related to abdominal surgery where most participants 
enrolled were female (Manzano et al., 2008; Mackay, Ellis & Johnston, 2005; Fagevik Olsén et al., 
1997; Hall, Tarala, Tapper & Hall, 1996; Hall et al., 1991). In none of the referenced articles above 
was there a correlation between gender and an increased risk for the development of PPCs in 
abdominal surgery patients. This is similar in the current study sample. In conclusion, the profile of 
participants enrolled in the current study was similar to earlier research where the majority 
participants were female (Manzano et al., 2008; Mackay, Ellis & Johnston, 2005; Fagevik Olsén et 
al., 1997; Hall et al., 1996; Hall et al., 1991) and admitted for cancer related abdominal procedures 
(Silva, Li & Rickard, 2012; Browning, Denehy & Scholes, 2007). 
4.3 Post-operative Pulmonary complications 
One of the objectives was to investigate the effects the additional use of the Blow Bottle had on the 
development of PPCs and, to determine whether this effect was more beneficial than conventional 
post-operative cardio-respiratory physiotherapy alone, that is, did the additional use of the Blow 
Bottle reduce the incidence of PPCs. However, this objective was not met and the researcher 
attributes it to the criteria used to diagnose the presence of a PPC as described by Mackay et al. 
(2005). A PPC was deemed present if a patient had a combination of three or more changes in the 
following: auscultation, temperature, X-rays, or sputum, within the same day, during the first 14 post-
operative days.  
For this study, none of the participants had three or more changes on the same post-operative day. 
However, all participants displayed changes in either one or a combination of the aforementioned 
criteria for the development of a PPC. Most participants exhibited changes in auscultation findings 
across the first three post-operative days. More specifically, three patients exhibited radiological 
changes, which were indicative of pneumonia (n=1; IG) and atelectasis (n=2; CG) on day 2 and 5 
respectively. Strictly following the criteria as set out by Mackey et al. (2005), these three participants 
did not develop a PPC as three or more changes did not occur on the same day. Herewith lies the 
controversy, as there is no standardization for the criteria for the development of a PPC, nor its 
definition (Conde & Lawrence, 2008; Mackay, Ellis & Johnston, 2005; Smetana, 1999; Lawrence, 
Dhanda, Hilsenbeck & Page, 1996). The criteria by Mackay et al. (2005) consists of objective 
measures to define a PPC, such as auscultation, temperature, sputum, and X-ray findings that are 
obtainable by the physiotherapist and forms part of the physiotherapist’s daily assessment. However, 
the criteria rely on the assumption that X-rays are performed routinely post-operatively. However, as 
this study was set in a public tertiary institution, X-rays were not done routinely post-operatively 
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probably due to steps to curtail costs. Thus, this made the use of radiological changes as seen on X-
ray as part of the criteria to diagnose a PPC for physiotherapists, problematic.  
This was further compounded as the median range of hospital stay varied between the CG and IG (5-
34 days in the CG compared to 6-20 days in the IG) with the majority of participants discharged from 
physiotherapy within 2 to 3 days post-surgery and exited the study. This made comparisons between 
groups on each individual day statistically challenging. Due to this large drop out after the first three 
post-operative days, sub-analysis of the composite variables were used to conduct analyses and was 
recorded as any change that may have occurred across the duration of the study (see 3.4, figure 4). 
Sub-analysis of the composite PPC variables showed that changes from the pre-operative existed 
across both groups and across all variables.  
Majority of the participants across groups developed changes in auscultation on the first post-
operative day. This was comparable to the findings of Mackay et al. (2005), where 60% of 
participants developed changes in auscultation findings post-operatively. In the current study, the 
change in auscultation findings exhibited by majority of participants was that of decreased breath 
sounds. The decreased ability to expand the chest and inspire is widely reported following open 
abdominal surgery, where the larger incision may lead to diaphragmatic dysfunction (Siafakas et al., 
1999; Frazee et al., 1991; Chuter et al., 1990). Breathing at low tidal volumes may lead to the 
development of passive atelectasis (Kacmarek, Stoller & Heuer, Egans Fundamentals of Respiratory 
Care, 2013, pp. 904). The incision site and disruption of the abdominal muscles affects the patient’s 
ability to produce a forced expiratory manoeuvre required to cough effectively and remove secretions 
that may be present (Tzani, Chetta & Olivieri, 2011; Richardson & Sabanathan, 1997; Roussos, 
1985). Retention of secretions and mucus plugging can lead to the development in resorption 
atelectasis and pneumonia (Kacmarek, Stoller & Heuer, Egans Fundamentals of Respiratory Care, 
2013, pp. 904).  
In this study, three participants developed changes that warranted further imaging investigation. On 
the second post-operative day, one participant from the CG developed a temperature greater than 
38˚C and referred for a Chest CT that reported a right pleural effusion and atelectasis. On the fifth 
post-operative day, two participants, one from the CG and one from the IG, developed abnormal lung 
sounds on auscultation; these being crepitation and wheezes indicative of pathology. They were 
referred for Chest CTs that reported atelectasis and possible pneumonia for the participant in the CG 
and atelectasis for the participant in the IG. The surgical incision site not only negatively affects the 
respiratory muscles and the patient’s ability to breathe deeply and cough effectively, increasing the 
risk of the development of PPCs, but also causes post-operative pain and hesitation to mobilize 
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(Tzani, Chetta & Olivieri, 2011; Richardson & Sabanathan, 1997). This may result in participants 
being hesitant to mobilize post-operatively due to fear of damaging the wound site or possible pain 
with mobilization (Cheifetz, Lucy, Overend & Crowe, 2010; Browning, Denehy & Scholes, 2007).  
In the current study, majority of the participants were unable to mobilize on the first post-operative 
day and were reliant on assistance from the physiotherapist or nursing staff. This may have led to 
participants being mobilized less frequently due to human resource constraints. This is in conflict with 
evidenced based practice that advocates early and frequent mobilization to improve post-operative 
lung function and thus reduce the development of a PPC (Silva, Li & Rickard, 2012; Cheifetz et al., 
2010; Varadhan, Neal, Dejong, Fearon, Ljungqvist, 2010; Browning, Denehy & Scholes, 2007; 
Mackay, Ellis & Johnston, 2005; Fagevik Olsén et al., 1997).  
Due to the large drop out of participants, but more so, as the criteria for the development of a PPC 
used for the current study proved to be difficult to implement within this public tertiary institution, 
inferences as to the efficacy of the Blow Bottle to impact or reduce the development of a PPC is 
inconclusive. Despite the small size, it is more probable that PPCs in this cohort may have been 
under-diagnosed.  
4.4 Lung Function  
In this study, the researcher chose spirometry to ascertain the effect of the Blow Bottle on lung 
function. In literature evaluating patients following abdominal surgery, spirometry is commonly used 
as an outcome measure (Mackay, Ellis & Johnston, 2005; Hasuki et al., 2002; Fagevik Olsén et al., 
1997; Joris, Kaba & Lamy, 1997). In the current study, pre-operative FEV1 and FVC measurements 
were similar across the IG and the CG except for one participant in the IG who had poor pre-operative 
lung function. Across both CG and IG, there was a drastic decline in FEV1 and FVC post-operatively. 
Across the groups, participants had a median drop of approximately 62% in FEV1 and 47% in FVC on 
the first post-operative day. A marked drop in lung function post-operatively was also reported in 
various other studies where reductions in FEV1 ranged from 33-50% and 20-36% in FVC on the first 
post-operative day in patients undergoing open abdominal surgery (Yildirim Osman, Serpil, Umit, 
Ebru, Bulent, Mete & Omer, 2009; Hasuki et al., 2002; Chumillas, Ponce, Delgado & Viciano, 1998; 
Joris, Kaba & Lamy, 1997).  
Various factors may influence the marked drop in lung function from pre-operative to post-operative. 
The type of surgery and the incision site itself, as previously described, disrupts the respiratory 
muscles, hindering inspiration and forced expiration (Tzani, Chetta & Olivieri, 2011; Richardson & 
Sabanathan, 1997; Roussos, 1985). This can be further aggravated by general anaesthesia. Typically 
the length of general anaesthesia for open abdominal surgery is approximately four hours (Mackay, 
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Ellis & Johnston, 2005). The application of general anaesthesia affects the patient’s lung function as 
the anaesthetic agents, mechanical ventilation used and the length of anaesthesia contributes to the 
collapse of alveoli and decreased respiratory muscle tone, which may lead to impaired oxygenation 
and carbon dioxide reabsorption (Hedenstierna, 2003). These effects may be present for many days 
post-operatively (Siafakas et al., 1999). In this cohort, poor FEV1 and FVC measurements were 
obtained across both CG and IG over the first three post-operative days of this study. This was similar 
to findings by Osman et al. (2009) and Schauer et al. (1993) where reductions in FEV1 and FVC after 
laparotomy were observed on the first post-operative day, only returning to normal pre-operative 
measurements by the sixth and tenth post-operative days respectively (Yildirim Osman et al., 2009; 
Schauer et al., 1993).  
In the current study, participants were required to use the Blow Bottle a minimum of ten times under 
the supervision of the physiotherapist. Additionally, participants were also requested to use the Blow 
Bottle at least ten times every waking hour on their own. The frequency of the self-administered use 
of the Blow Bottle was to be recorded using the logbook. The nurses were tasked with the duty of 
reinforcing the use of the Blow Bottle hourly and assist in the completion of the logbook. Participants 
and nursing staff agreed upon these aspects pre-operatively. Nevertheless, adherence to completing 
the logbook was very poor amongst participants, implying poor compliance with the self-
administration of the Blow Bottle. In the current study, when considering the effects the Blow Bottle 
had on lung function, there was no statistical difference between lung function findings across the CG 
and IG. This could be influenced by the poor compliance with the use of the Blow Bottle outside of 
the physiotherapy sessions. Improvements in FEV1 and FVC after the third post-operative day was 
not seen due to the loss of participants after the third post-operative day, because of the small sample 


















CHAPTER 5: CONCLUSION 
This study set out to determine whether the additional use of the Blow Bottle was more beneficial 
compared to conventional post-operative cardio-respiratory physiotherapy alone, by evaluating the 
effects on lung function and assessing the development of PPCs. None of the participants developed a 
PPC according to the criteria, although, three participants did have imaging findings indicative of the 
development of a PPC. In this setting, the criteria employed were unable to identify the development 
of a PPC. A statistically significant marked reduction in lung function parameters FEV1 and FVC was 
observed post-operatively with no statistical difference between groups. No conclusions as to the 
whether the additional use of the Blow Bottle is more beneficial can be drawn due to the small sample 
size. When using the Blow Bottle as a self-administered treatment, physiotherapists should be aware 
that patients might not adhere to the regime prescribed and thus reduce the efficacy of the technique. 
In particular, physiotherapist should be aware of settings with limited or stretched human resources, 
and how this may influence compliance to requests made for self-treatment. This study re-iterates the 
large detrimental effect that open abdominal surgery has on not only lung function but also mobility 
post-operatively. This study also highlights that literature for the use of the Blow Bottle in the 
abdominal surgical population is scant and outdated, and sorely lacking in the resource constraint 
South African hospital settings.  
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CHAPTER 6: LIMITATIONS AND RECOMMENDATIONS 
 
This study is largely limited by its small sample size. Over the total duration of the study (April 2014 
to December 2014), no eligible participants were enrolled from the private sector. The absence of 
participants enrolled from the private sector can be attributed to several factors. The study took place 
during a period when fewer open abdominal surgeries were performed, which could be ascribed to 
surgeons being away from their practices and to laparoscopic procedures being performed more than 
open abdominal surgeries. Also, within the chosen private institutions, consent to approach patients 
scheduled for surgery from one surgeon, who predominantly performed open abdominal surgeries, 
proved fruitless, as he refused to participate in the trial. In South Africa private health care institutions 
work on the basis of referral to physiotherapist and thus obtaining the required patient population 
would be impossible without referral from the attending surgeon. Furthermore the small sample size 
can be attributed to limited timeframe within the constraints of the funding which was only for a two 
year. Therefor continuing with the data collection process to achieve a minimum sample size was 
unfortunately not possible. The sample size therefore depicts the total amount of participants that was 
able to be included given the available time period. Due the slow uptake of patients and time 
constraints, the sample is therefore not purely heterogeneous, as although it includes only open 
abdominal surgical patients, they had varying procedures done. It is however recommended that 
future studies continue data collection for a longer duration or include multiple trial sites in order to 
achieve the appropriate homogenous sample size and allow for publishable data to be obtained.  
The criteria for the development of PPCs employed were also not ideally suited to this research 
setting. This raises the need for standardized clinical criteria for the development of PPCs (Conde & 
Lawrence, 2008; Mackay, Ellis & Johnston, 2005; Smetana, 1999; Lawrence et al., 1996).  
The researcher used spirometry as an evidenced based objective outcome measure, but this proved 
difficult, as accurate spirometry testing is reliant on the patient’s ability to follow commands, inspire 
maximally, and forcefully expire. This is hindered following open abdominal surgery (Tzani, Chetta 
& Olivieri, 2011; Hasuki et al., 2002; Joris, Kaba & Lamy, 1997; Richardson & Sabanathan, 1997; 
Coelho, de Araujo, Marchesini, Coelho & de Araujo, 1993). This was observed in our cohort with a 
number of participants struggling to perform adequate inspiration and expiration manoeuvres. 
Therefore, as evident in this study, spirometry may not be the best measurement for post-operative 
lung function in the abdominal-surgical population (Hall et al., 1991). In health care settings with 
limited human resources and cost constraints, other objective measures could be used to evaluate 
overall  lung function such as the Six Minute Walk Test (6MWT) (Cheifetz et al., 2010). However, 
the efficacy of this test may possibly be compounded by the patient’s hesitation to mobilize post-
operatively due to pain and fear of damaging the wound (Cheifetz et al., 2010; Browning, Denehy & 
Scholes, 2007). It is recommended that future studies examining the abdominal surgical population 
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record details as to why patients were unable to mobilize. A record of pain levels may be beneficial as 
this may be an influential factor impacting the patients’ willingness to mobilize.  
In this study, the researcher observed poor compliance with the self-administered use of the Blow 
Bottle. Visual cues and encouragement from the entire multi-disciplinary team is therefore 
recommended to promote the efficacy of the device. The need for further research investigating the 
abdominal surgical field and the use of tools such as the Blow Bottle, especially in the South African 
hospital setting and population, is highly recommended to improve evidenced based practise. This 
should ideally involve both private and public health care settings across a wider geographical area to 
compensate for the difficulty of research within the private health care sector and would benefit from 




Brooks-Brunn, J.A. 1995. Postoperative atelectasis and pneumonia. Heart & Lung: The Journal of 
Acute and Critical Care. 24(2): 94-115.  
Browning, L., Denehy, L. & Scholes, R.L. 2007. The quantity of early upright mobilisation performed 
following upper abdominal surgery is low: an observational study. Australian Journal of 
Physiotherapy. 53(1): 47-52.  
Campbell, T., Ferguson, N. & McKinlay, R. 1986. The use of a simple self-administered method of 
positive expiratory pressure (PEP) in chest physiotherapy after abdominal surgery. 
Physiotherapy. 72(10):498-500. 
Canet, J. & Mazo, V. 2010. Postoperative pulmonary complications. Minerva Anestesiologica. 76(2): 
138.  
Cheifetz, O., Lucy, S.D., Overend, T.J. & Crowe, J. 2010. The effect of abdominal support on 
functional outcomes in patients following major abdominal surgery: a randomized controlled 
trial. Physiotherapy Canada. 62(3): 242-253.  
Christensen, E.F., Jensen, R.H., Schonemann, N.K. & Petersen, K.D. 1995. Flow-dependent 
properties of positive expiratory pressure devices. Monaldi Archives for Chest Disease = 
Archivio Monaldi Per Le Malattie Del Torace / Fondazione Clinica Del Lavoro, IRCCS [and] 
Istituto Di Clinica Tisiologica e Malattie Apparato Respiratorio, Universita Di Napoli, Secondo 
Ateneo. 50(2): 150-153.  
Chumillas, M., Ponce, J.L., Delgado, F. & Viciano, V. 1998. Pulmonary function and complications 
after laparoscopic cholecystectomy. European Journal of Surgery. 164(6): 433-437.  
Chuter, T., Weissman, C., Mathews, D. & Starker, P. 1990. Diaphragmatic breathing maneuvers and 
movement of the diaphragm after cholecystectomy. CHEST Journal. 97(5): 1110-1114.  
Clini, E. 2009. Positive expiratory pressure techniques in respiratory patients: old evidence and new 
insights. Breathe. 6(2): 153-159.  
Coelho, J.C., de Araujo, R.P., Marchesini, J.B., Coelho, I.C. & de Araujo, L.R. 1993. Pulmonary 
function after cholecystectomy performed through Kocher's incision, a mini-incision, and 
laparoscopy. World Journal of Surgery. 17(4): 544-546.  
Conde, M. & Lawrence, V. 2008. Postoperative pulmonary infections. Clinical Evidence. 2008.  
De Pietri, L., Montalti, R. & Begliomini, B. 2014. Anaesthetic perioperative management of patients 
with pancreatic cancer. World Journal of Gastroenterology : WJG. 20(9):2304-2320.  
59 
 
Darbee, J.C., Ohtake, P.J., Grant, B.J. & Cerny, F.J. 2004. Physiologic evidence for the efficacy of 
positive expiratory pressure as an airway clearance technique in patients with cystic fibrosis. 
Physical Therapy. 84(6): 524-537.  
Fagevik Olsén, M., Hahn, I., Nordgren, S., Lönroth, H. & Lundholm, K. 1997. Randomized 
controlled trial of prophylactic chest physiotherapy in major abdominal surgery. British Journal 
of Surgery. 84(11): 1535-1538.  
Fiore, J.F., Chiavegato, L.D., Paisani, D.M. & Colucci, D.B. 2010. Utilization of positive-pressure 
devices for breathing exercises in the hospital setting: A regional survey in Sao Paulo, Brazil. 
Respiratory Care. 55(6): 719-724.  
Frazee, R.C., Roberts, J.W., Okeson, G.C., Symmonds, R.E., Snyder, S.K., Hendricks, J.C. & Smith, 
R.W. 1991. Open versus laparoscopic cholecystectomy. A comparison of postoperative 
pulmonary function. Annals of Surgery. 213(6): 651.  
Grantcharov, T.P. & Rosenberg, J. 2001. Vertical compared with transverse incisions in abdominal 
surgery. European Journal of Surgery. 167(4): 260-267.  
Hall, J., Tarala, R., Hall, J. & Mander, J. 1991. A multivariate analysis of the risk of pulmonary 
complications after laparotomy. CHEST Journal. 99(4): 923-927.  
Hall, J.C., Tarala, R.A., Tapper, J. & Hall, J.L. 1996. Prevention of respiratory complications after 
abdominal surgery: a randomised clinical trial. BMJ: British Medical Journal. 312(7024): 148.  
Hanekom, S.D., Brooks, D., Denehy, L., Fagevik-Olsén, M., Hardcastle, T.C., Manie, S. & Louw, Q. 
2012. Reaching consensus on the physiotherapeutic management of patients following upper 
abdominal surgery: a pragmatic approach to interpret equivocal evidence. BMC Medical 
Informatics and Decision Making. 12(1): 5.  
Hasuki, Š., Meši, D., Dizdarevi, E., Keser, D., Hadiselimovi, S. & Bazardanovi, M. 2002. Pulmonary 
function after laparoscopic and open cholecystectomy. Surgical Endoscopy. 16(1): 163-165.  
Hedenstierna, G. 2003. Alveolar collapse and closure of airways: regular effects of anaesthesia. 
Clinical Physiology and Functional Imaging. 23(3): 123-129.  
Heisterberg, L., Johansen, T.S., Larsen, H.W., Holm, M. & Andersen, B. 1979. Postoperative 
pulmonary complications in upper abdominal surgery. A randomized clinical comparison 
between physiotherapy and blow-bottles. Acta Chirurgica Scandinavica. 145(8):505-507. 
60 
 
Johansson, H., Sjöholm, R., Stafberg, A. & Westerdahl, E. 2013. Breathing Exercises with Positive 
Expiratory Pressure after Abdominal Surgery–The Current Physical Therapy Practice in Sweden. 
J Anesthe Clinic Res. 4(325): 2.  
Johnston, C.L., James, R. & Mackney, J.H. The current use of positive expiratory pressure (PEP) 
therapy by public hospital physiotherapists in New South Wales. LINKING THE CHAIN. 88.  
Joris, J., Kaba, A. & Lamy, M. 1997. Postoperative spirometry after laparoscopy for lower abdominal 
or upper abdominal surgical procedures. British Journal of Anaesthesia. 79(4): 422-426.  
Kacmarek, R.M., Stoller, J.K. & Heuer, A.J. 2013. Egan's fundamentals of respiratory care. 
Elsevier/Mosby.  
Kanonidou, Z. & Karystianou, G. 2007. Anesthesia for the elderly. Hippokratia. 11(4): 175-177.  
Koegelenberg, C.F.N., Swart, F. & Irusen, E.M. 2013. Guideline for office spirometry in adults, 2012. 
SAMJ: South African Medical Journal. 103(1): 52-61.  
Lawrence, V.A., Dhanda, R., Hilsenbeck, S.G. & Page, C.P. 1996. Risk of pulmonary complications 
after elective abdominal surgery. CHEST Journal. 110(3): 744-750.  
Mackay, M.R. & Ellis, E. 2002. Physiotherapy outcomes and staffing resources in open abdominal 
surgery patients. Physiotherapy Theory and Practice. 18(2): 75-93.  
Mackay, M.R., Ellis, E. & Johnston, C. 2005. Randomised clinical trial of physiotherapy after open 
abdominal surgery in high-risk patients. Australian Journal of Physiotherapy. 51(3): 151-159.  
Manzano, R.M., Carvalho, Celso Ricardo Fernandes de, Saraiva-Romanholo, B.M. & Vieira, J.E. 
2008. Chest physiotherapy during immediate post-operative period among patients undergoing 
upper abdominal surgery: randomized clinical trial. Sao Paulo Medical Journal. 126(5): 269-
273.  
Mestriner, R.G., Fernandes, R.O., Steffen, L.C. & Donadio, M. 2009. Optimum design parameters for 
a therapist-constructed positive-expiratory-pressure therapy bottle device. Respiratory Care. 
54(4): 504-508.  
Miller, M.R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P. 
et al. 2005. Standardisation of spirometry. Eur Respir J. 26(2): 319-338.  
Myers, T.R. 2007. Positive expiratory pressure and oscillatory positive expiratory pressure therapies. 
Respiratory Care. 52(10): 1308-1327.  
61 
O'Donohue, W.J. 1992. Postoperative pulmonary complications. When are preventive and therapeutic 
measures necessary? Postgraduate Medicine. 91(3): 167-70, 173-5. 
Olsén, M.F., Lannefors, L. & Westerdahl, E. 2015. Positive expiratory pressure–Common clinical 
applications and physiological effects. Respiratory Medicine. 109(3):297-307. 
Orman, J. & Westerdahl, E. 2010. Chest physiotherapy with positive expiratory pressure breathing 
after abdominal and thoracic surgery: a systematic review. Acta Anaesthesiol Scand. 54(3): 261-
267.  
Pasquina, P., Tramèr, M., Granier, J.M. & Walder, B. 2006. Respiratory physiotherapy to prevent 
pulmonary complications after abdominal surgery: a systematic review. Chest. 130(6): 1887-
1899.  
Quanjer, P.H., Stanojevic, S., Cole, T.J., Baur, X., Hall, G.L., Culver, B.H., Enright, P.L., Hankinson, 
J.L. et al. 2012. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the
global lung function 2012 equations. The European Respiratory Journal. 40(6): 1324-1343.
DOI:10.1183/09031936.00080312 [doi].
Richardson, J. & Sabanathan, S. 1997. Prevention of respiratory complications after abdominal 
surgery. Thorax. 52(Suppl 3): S35. 
Ricksten, S., Bengtsson, A., Soderberg, C., Thorden, M. & Kvist, H. 1986. Effects of periodic 
positive airway pressure by mask on postoperative pulmonary function. CHEST Journal. 89(6): 
774-781.
Roussos, C. 1985. Function and fatigue of respiratory muscles. Chest. 88(2 Supplement): 124S-132S. 
Schmidt GB. 1977. Prophylaxis of pulmonary complications following abdominal surgery, including 
atelectasis, ARDS, and pulmonary embolism. Surg Annu. 9: 29-73. 
Schauer, P.R., Luna, J., Ghiatas, A.A., Glen, M.E., Warren, J.M. & Sirinek, K.R. 1993. Pulmonary 
function after laparoscopic cholecystectomy. Surgery. 114(2): 389-97; discussion 397-9. 
Sehlin, M., Ohberg, F., Johansson, G. & Winso, O. 2007. Physiological responses to positive 
expiratory pressure breathing: a comparison of the PEP bottle and the PEP mask. Respiratory
Care. 52(8): 1000-1005.  
Siafakas, N., Mitrouska, I., Bouros, D. & Georgopoulos, D. 1999. Surgery and the respiratory 
muscles. Thorax. 54(5): 458-465. 
62 
 
Silva, Y., Li, S. & Rickard, M. 2012. Does the addition of deep breathing exercises to physiotherapy-
directed early mobilisation alter patient outcomes following high-risk open upper abdominal 
surgery? Physiotherapy.  
Smetana, G.W. 1999. Preoperative pulmonary evaluation. New England Journal of Medicine. 
340(12): 937-944.  
Sprung, J., Gajic, O. & Warner, D.O. 2006. Review article: age related alterations in respiratory 
function—anesthetic considerations. Canadian Journal of Anesthesia. 53(12): 1244-1257.  
Stiller KR and Munday RM. 1992. Chest physiotherapy for the surgical patient. Br J Surg. 79: 745-
749. 
Tang, C.Y., Taylor, N.F. & Blackstock, F.C. 2010. Chest physiotherapy for patients admitted to 
hospital with an acute exacerbation of chronic obstructive pulmonary disease (COPD): a 
systematic review. Physiotherapy. 96(1):1-13. 
Thomas, J.A. & McIntosh, J.M. 1994. Are incentive spirometry, intermittent positive pressure 
breathing, and deep breathing exercises effective in the prevention of postoperative pulmonary 
complications after upper abdominal surgery? A systematic overview and meta-analysis. 
Physical Therapy. 74(1): 3-10.  
Thorѐn L. Post-operative pulmonary complications. Observations on their prevention by means of 
physiotherapy. Acta Chirurgica Scandinavica. 107: 193-205. 
Tzani, P., Chetta, A. & Olivieri, D. 2011. Patient assessment and prevention of pulmonary side effects 
in surgery. Current Opinion in Anaesthesiology. 24(1): 2-7.  
Varadhan, K.K., Neal, K.R., Dejong, C.H., Fearon, K.C., Ljungqvist, O. & Lobo, D.N. 2010. The 
enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open 
colorectal surgery: a meta-analysis of randomized controlled trials. Clinical Nutrition. 29(4): 
434-440.  
von Ungern‐Sternberg, B., Regli, A., Schneider, M., Kunz, F. & Reber, A. 2004. Effect of obesity and 
site of surgery on perioperative lung volumes. British Journal of Anaesthesia. 92(2): 202-207.  
Yildirim Osman, A.F., Serpil, A., Umit, T., Ebru, M., Bulent, U., Mete, D. & Omer, C. 2009. The 




http://www.lifehealthcare.co.za/Hospitals/DisplayHospital.aspx?nHospitalId=28 as accessed on 1 
March 2015. 
http://www.westerncape.gov.za/text/2009/3/fast_facts_gsh_jan09.pdf  as accessed on 1 March 2015.  







Appendix A: Adapted Abdominal Surgery Physiotherapy Outcomes Data Sheet (A-APODS) 
ADAPTED ABDOMINAL SURGERY PHYSIOTHERAPY OUTCOMES DATA SHEET 
PRE-OPERATIVE RECORD 
 (TO BE COMPLETED BY RESEARCH TEAM) 
PATIENT NAME: CODE:  
TYPE OF SURGERY SCHEDULED: 
DATE OF SCHEDULED SURGERY: 
TODAY’S DATE: 
NAME OF PHYSIOTHERAPIST: 
DEMOGRAPHIC INFORMATION 
GENDER: MALE/FEMALE (INSERT M OR F)  
DOB: HEIGHT:                                                         
cm                                                                    
AGE: WEIGHT:                                                        
kg 
MEDICAL HISTORY: Y/N 
DIABETES  LIVER DISEASE  
COPD  KIDNEY DISEASE  
EMPHYSEMA  PREVIOUS STROKE  
ASTHMA  HISTORY OF CANCER  
OTHER LUNG DISEASE 
(SPECIFY) 
 PREV. ABDOMINAL SURGERY  




SMOKER? Y/N  IF YES, CIGARETTES PER 
DAY? 
 




ANY RESPIRATORY SYMPTOMS WITHIN THE LAST 2 WEEKS? 
ANY CARDIAC SYMPTOMS WITHIN THE LAST 2 WEEKS? 
SPIROMETRY 
FEV1: FVC: 
AUSCULTATION: TICK IN COLUMN ON RIGHT 
NORMAL BREATHE SOUNDS  
DECREASED BREATHE SOUNDS  
MINIMAL CREPITATION AND WHEEZES  
WIDESPREAD CREPITATION AND WHEEZES  
SPUTUM: TICK IN COLUMN ON RIGHT (2 TICKS) 
NO SPUTUM  
SMALL AMOUNT (1-2tsp)  
MODERATE AMOUNT (UP TO ¼ CUP)  
LARGE AMOUNT (>¼ CUP)   
NO COLOUR (CLEAR/WHITE)  
COLOUR (PURULENT)  
CHEST X-RAY: TICK IN COLUMN ON RIGHT 












MINOR UNSPECIFIED CHANGES OR 
ANY MENTION OF CONSOLIDATION AND/OR ATELECTASIS 
(SEGMENTALLY OR ONE LOBE) 
 
PRONOUNCED (BILATERAL OR WHOLE LOBE)  
CONSOLIDATON/AND OR ATELECTASIS 
 
COGNITIVE FUNCTION:  TICK IN COLUMN ON RIGHT 
ORIENTATED TO TIME/PERSON/PLACE  
DIFFICULTY FOLLOWING DIRECTIONS  
UNABLE TO FOLLOW DIRECTIONS/DECREASED LEVEL OF 
CONSCIOUSNESS 
 
MOBILITY INDICATORS:  TICK IN COLUMN ON RIGHT 
WALKING WITH ASSISTIVE DEVICE  
MOBILE WITH NO ASSISTANCE  
IMMOBILE  
ADAPTED ABDOMINAL SURGERY PHYSIOTHERAPY OUTCOMES DATA SHEET 
POST-OPERATIVE RECORD 
PATIENT NAME: CODE:  
TYPE OF SURGERY: 
DATE OF SURGERY: TODAY’S DATE: POST-OP DAY: 
DATE OF D/C  FROM:  PHYSIO: HOSP: 
ATTACHMENTS 
 INSERT YES OR 
NO 
(Y OR N) 
IF YES, INSERT 
TODAY’S VALUE 
STOMA   
DRAIN (SPECIFY)   
NGT (ON DRAINAGE)   
EPIDURAL  NO VALUE 
REQUIRED 
PCA  NO VALUE 
REQUIRED 
URINARY CATHETER  NO VALUE 
REQUIRED 
OTHER (SPECIFY)   
VITALS (PLEASE INSERT VALUES) 
SATURATION:                                                      
% 
OXYGEN:                                                       
LITRES 
HR: RR: BP: 





AUSCULTATION: TICK IN COLUMN ON RIGHT 
NORMAL BREATHE SOUNDS  








MINIMAL CREPITATIONS AND WHEEZES  
WIDESPREAD CREPITATIONS AND WHEEZES  
SPUTUM: TICK IN COLUMN ON RIGHT (2 TICKS) 
NO SPUTUM  
SMALL AMOUNT (1-2tsp)  
MODERATE AMOUNT (UP TO ¼ CUP)  
LARGE AMOUNT (>¼ CUP)   
NO COLOUR (CLEAR/WHITE)  
CHEST X-RAY: TICK IN COLUMN ON RIGHT  
NO X-RAY TODAY  
NORMAL  
MINOR UNSPECIFIED CHANGES OR 
ANY MENTION OF CONSOLIDATION AND/OR ATELECTASIS 
(SEGMENTALLY OR ONE LOBE) 
 
PRONOUNCED (BILATERAL OR WHOLE LOBE)  
CONSOLIDATON/AND OR ATELECTASIS 
 
COGNITIVE FUNCTION:  TICK IN COLUMN ON RIGHT  
ORIENTATED TO TIME/PERSON/PLACE  
DIFFICULTY FOLLOWING DIRECTIONS  
UNABLE TO FOLLOW DIRECTIONS/DECREASED LEVEL OF 
CONSCIOUSNESS 
 
MOBILITY INDICATORS:  TICK IN COLUMN ON RIGHT  
WALKING WITH ASSISTIVE DEVICE  
MOBILE WITH NO ASSISTANCE  
IMMOBILE  








BLOW BOTTLE  
DOES PATIENT HAVE A BB? Y/N  
REPS AND SETS:  
DURATION OF EXPIRATION: IN SECONDS  
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Appendix C: Blow Bottle Logbook 
 
BLOW BOTTLE LOGBOOK 
PHYSIOTHERAPY CLINICAL TRIAL 
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Appendix D: Ethical Approval Letter 
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Appendix E: Amended and Renewed Ethical Approval Letter 
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Appendix F: Approval Letter (Life Healthcare)   
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Appendix G: Approval Letter (Groote Schuur Hospital)
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You are invited to participate in a study conducted by Rene Jacobs, in fulfilment of a Physiotherapy Master’s 
Degree through the University of Cape Town. The study is entitled “Evaluation of Positive Expiratory Pressure 
(PEP) devices as an adjunct to physiotherapy in patients following open abdominal surgery”. 
Purpose of the study: 
PEP therapy was developed in Denmark in the 1970’s. It includes the use of devices that provide some 
resistance while you breathe out, and has been shown to assist with improving lung function. For this study, the 
PEP device that will be used is the Blow Bottle. This is a simple device consisting of a plastic bottle filled 
halfway with water, with a tube in it. When you blow through this tube, you create a stream of bubbles, and the 
water acts as resistance. Studies investigating the effectiveness of the Blow Bottle are very old, some dating 
back to the 70’s, however, this device is used commonly in South Africa as it is inexpensive and simple to use. 
Not enough research on the use of this Blow Bottle device in clinical practise exists, and the benefits of the 
device have not been properly investigated, especially in patients undergoing abdominal surgery. Physiotherapy 
after abdominal surgery has shown to benefit patients and has become part of the routine post-operative 
management of patients undergoing abdominal surgery, but adding the Blow Bottle to physiotherapy treatment 
has not been properly evaluated. This study serves to add to the existing knowledge about the Blow Bottle, and 
investigate how useful this device may be when added to a physiotherapy treatment. Findings from this study 
will hopefully improve physiotherapy in South Africa. 
Selection of participants: 
You have been selected to participate in this study as you have been scheduled for abdominal surgery. 
Description of the study: 
As part of the study, you will also be required to undergo a pre-operative session with the research team. This 
session serves to get baseline information such as medical history, including a lung function test using a 
portable lung function-testing machine called a Spirometer. You breathe into a tube 3 times and the machine 
measures your lung function. The test takes less than 10 minutes to complete. You will be contacted 
telephonically to arrange this consultation. This session will take no longer than 20 minutes.  
Evaluation of Positive Expiratory Pressure (PEP) devices as an adjunct to 
physiotherapy in patients following abdominal surgery 
 
Miss Rene Jacobs 
(in fulfilment of a Physiotherapy Master’s Degree by dissertation through the University of Cape 
Town) 
 
HREC REF: 493/2013 
Student Number: JCBREN005 









This study’s format is a Randomized Control Trial (RCT). This means that the participants consenting to be part 
of the trial will be divided randomly into two groups: one group receiving normal post-operative physiotherapy, 
and the other group receiving normal post-operative physiotherapy with the additional use of the Blow Bottle. 
On the first day after your surgery, prior to your first physiotherapy treatment, you will be will randomly 
assigned to a group. Both groups will receive normal physiotherapy, which is the standard care of the hospital. 
This physiotherapy treatment includes getting out of bed, deep breathing exercises, coughing, and other 
physiotherapy techniques that will assist in maintaining and improving your lung function and get you back on 
your feet. The group receiving the Blow Bottle will receive normal physiotherapy, but in their session, they will 
be asked to use the Blow Bottle device. If you form part of this group, you will be asked to perform the Blow 
Bottle exercise for 10 blows every waking hour. Participants will be given a logbook to record when they have 
used the Blow Bottle. The logbook is used to document if you use the Blow Bottle without the physiotherapist, 
and must be signed off by the nursing staff each time you use the Blow Bottle every hour. 
Both groups will be given physiotherapy at least once daily. The physiotherapist will collect daily data from 
your treatment such as information about your surgery and wound site, the physiotherapy treatment you are 
receiving, details of any lung or other complications that may or may not happen, how you are mobilizing in the 
ward, and how long you stay in hospital. This forms part of the general physiotherapy assessment you would 
have if you were not part of the study, and is documented more specifically for the purposes of this study.  
The research team will also come every second day to assess your lung function using the spirometer, starting 
on the first day you have your surgery until the day you are discharged from physiotherapy or the hospital. This 
is done exactly how it was done in the pre-operative session. They will come and conduct the lung function test 
at your bedside.  
The research team will be unaware of which group you have been allocated to. Therefore, you are requested to 
not tell the research team which group you have been allocated to. The study will continue for the time that you 
spend in hospital or until your physiotherapist deems you suitable to discontinue physiotherapy.  
Risks and Benefits: 
As a participant, you will be required to attend a pre-operative session to retrieve baseline information. You will 
not be expected to pay for this session, but will also not receive any monetary compensation for this session in 
terms of time and cover for travelling costs. If you do not consent to participate in this pre-operative session, 
then you will be excluded from the study. This will by no means affect the physiotherapy you receive or the 
service provided to you in hospital. 
You will be receiving conventional physiotherapy after your surgery. This forms part of the regular practice of 
the hospital and is the routine care you would receive if you were not part of the study. This means that you are 
responsible for payment of the physiotherapy services, as per the routine practices of the hospital. Physiotherapy 
has proven to be beneficial, but can cause exhaustion during the treatment. In addition, physiotherapy includes 
the use of deep breathing exercises and coughing that might be painful due to the surgical wound. Physiotherapy 
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after abdominal surgery is routinely given in the hospital setting and is used to reduce the risk of lung infections 
and improve your function.  
Your lung function will be tested by the research team using the lung function machine. This test in less than 10 
minutes long, but you should be made aware that this test might cause some exhaustion, as it requires you to 
breathing deeply and exhale rapidly. This test was shown to not be harmful and the information from these tests 
are very important for this study. 
By being part of this study, you will receive the exact level of care and physiotherapy treatment you would have 
received if you were not participating in the study. However, by being part of the study, you will allow us to get 
information so that we can improve the level of care patients receive in hospital. 
Contact Details: 
If you have any queries, or need more information about your rights as a research participant, you may contact 
Rene Jacobs (primary investigator), Mrs Shamila Manie (Masters Supervisor), or the Health Sciences Human 
Research Ethics Committee (HREC) of the University of Cape Town. 
Primary investigator:  Rene Catherine Jacobs (UCT Masters student) 
 0827726423 
Supervisor:   Mrs Shamila Manie 
(021) 406-6571










Information regarding study 
You are invited to participate in a study conducted by Rene Jacobs, in fulfilment of a Physiotherapy Master’s 
Degree through the University of Cape Town. The study is entitled “Evaluation of Positive Expiratory Pressure 
(PEP) devices as an adjunct to physiotherapy in patients following open abdominal surgery”. 
Confidentiality: 
When information is collected, it will be captured and coded so that you remain anonymous. This data will be 
given to the primary researcher, Rene Jacobs and put in the Masters Thesis. This data will form part of articles 
that will hopefully be published in a health science journal. 
What if Something Goes Wrong? 
The University of Cape Town (UCT) undertakes that in the event of you suffering any significant deterioration 
in health or well-being, or from any unexpected sensitivity or toxicity that is caused by your participation in the 
study, it will provide immediate medical care. UCT has appropriate insurance cover to provide prompt payment 
of compensation for any trial-related injury according to the guidelines outlined by the Association of the British 
Pharmaceutical Industry, ABPI 1991. Broadly speaking, the ABPI guidelines recommend that the insured 
company (UCT), without legal commitment, should compensate you without you having to prove that UCT is at 
fault. An injury is considered trial-related if, and to the extent that, it is caused by study activities. You must 
notify the study doctor immediately of any side effects and/or injuries during the trial, whether they are 
research-related or other related complications. 
UCT reserves the right not to provide compensation if, and to the extent that, your injury came about because 
you chose not to follow the instructions that you were given while you were taking part in the study. Your right 
in law to claim compensation for injury where you prove negligence is not affected. Copies of these guidelines 
are available on request. 
You are free to not participate in the study, or stop participating at any point. This will in no way affect your 
hospital stay, your physiotherapy treatment, or the level of hospital care you receive. You are also not obligated 
to give an explanation for the above.  
Evaluation of Positive Expiratory Pressure (PEP) devices as an adjunct to 
physiotherapy in patients following abdominal surgery 
 
Miss Rene Jacobs 
(in fulfilment of a Physiotherapy Master’s Degree by dissertation through the University of Cape 
Town) 
 
HREC REF: 493/2013 
Student Number: JCBREN005 








Statement of Consent: 
I have read the above information and the information contained within the information letter. I have asked 
questions and have received answers. I understand the meaning of confidentiality. I understand that I have the 
right to refuse to participate in the study. 








If you have any queries, or need more information about your rights as a research participant, you may contact 
Rene Jacobs (primary investigator), Mrs Shamila Manie (Masters Supervisor), or the Health Sciences Human 
Research Ethics Committee (HREC) of the University of Cape Town. 
Primary investigator:  Rene Catherine Jacobs (UCT Masters student) 
 0827726423 
Supervisor:   Mrs Shamila Manie 
(021) 406-6571
HREC UCT:  Professor Marc Blockman (Chairperson of HREC) 
 www.health.uct.ac.za 
(021) 4066496
